<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS Genet</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosgen</journal-id>
<journal-title-group>
<journal-title>PLOS Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1553-7390</issn>
<issn pub-type="epub">1553-7404</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pgen.1006842</article-id>
<article-id pub-id-type="publisher-id">PGENETICS-D-17-00499</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Viewpoints</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>DNA-binding proteins</subject><subj-group><subject>Polymerases</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>DNA</subject><subj-group><subject>DNA damage</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Nucleic acids</subject><subj-group><subject>DNA</subject><subj-group><subject>DNA damage</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>DNA</subject><subj-group><subject>DNA replication</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Nucleic acids</subject><subj-group><subject>DNA</subject><subj-group><subject>DNA replication</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancer treatment</subject><subj-group><subject>Cancer chemotherapy</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pharmaceutics</subject><subj-group><subject>Drug therapy</subject><subj-group><subject>Chemotherapy</subject><subj-group><subject>Cancer chemotherapy</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Clinical medicine</subject><subj-group><subject>Clinical oncology</subject><subj-group><subject>Cancer chemotherapy</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Clinical oncology</subject><subj-group><subject>Cancer chemotherapy</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancer treatment</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Experimental organism systems</subject><subj-group><subject>Model organisms</subject><subj-group><subject>Mouse models</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Model organisms</subject><subj-group><subject>Mouse models</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Experimental organism systems</subject><subj-group><subject>Animal models</subject><subj-group><subject>Mouse models</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and neoplasms</subject><subj-group><subject>Lung and intrathoracic tumors</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Chromosome biology</subject><subj-group><subject>Chromosomes</subject><subj-group><subject>Chromosome structure and function</subject><subj-group><subject>Telomeres</subject><subj-group><subject>Telomere length</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Inhibition of mutagenic translesion synthesis: A possible strategy for improving chemotherapy?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-5539-4391</contrib-id>
<name name-style="western">
<surname>Yamanaka</surname>
<given-names>Kinrin</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-6556-9423</contrib-id>
<name name-style="western">
<surname>Chatterjee</surname>
<given-names>Nimrat</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-6776-2163</contrib-id>
<name name-style="western">
<surname>Hemann</surname>
<given-names>Michael T.</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-7243-8261</contrib-id>
<name name-style="western">
<surname>Walker</surname>
<given-names>Graham C.</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Koch Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Jinks-Robertson</surname>
<given-names>Sue</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Duke University, UNITED STATES</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">gwalker@mit.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>17</day>
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<month>8</month>
<year>2017</year>
</pub-date>
<volume>13</volume>
<issue>8</issue>
<elocation-id>e1006842</elocation-id>
<permissions>
<copyright-year>2017</copyright-year>
<copyright-holder>Yamanaka et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pgen.1006842"/>
<funding-group>
<funding-statement>This Viewpoints was supported by the National Institute of Environmental Health Sciences grants ES015818 to GCW. and P30 ES002109 to MIT and by the Ludwig Foundation to MTH. GCW is an American Cancer Society Professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="3"/>
<table-count count="1"/>
<page-count count="16"/>
</counts>
</article-meta>
</front>
<body>
<sec id="sec001">
<title>Overview</title>
<p>DNA damaging chemotherapy is the first line of treatment for certain cancers, but its long-term success is often marred by the eventual acquisition of chemoresistance. Other cancers cannot be treated because they are intrinsically resistant to such chemotherapy. These 2 types of resistance are coupled in the context of translesion synthesis (TLS), which is carried out by specialized TLS DNA polymerases that can replicate past DNA lesions but in a lower fidelity manner. First, TLS DNA polymerases permit the bypass of modified DNA bases during DNA synthesis, thereby allowing proliferation to continue in the presence of chemotherapy, an issue of particular relevance to intrinsic drug resistance. Second, mistakes introduced by TLS polymerases copying over DNA lesions introduced during the chemotherapy lead to mutations that contribute to acquired resistance. These dual functions of mutagenic TLS polymerases with respect to chemoresistance make these proteins very promising targets for adjuvant therapy. The major branch of mutagenic TLS requires REV1, a Y family DNA polymerase that recruits other TLS polymerases with its C-terminal domain (CTD) including POL ζ, which is also required. Recent evidence obtained using mouse models is summarized, which shows that interfering with REV1/POL ζ-dependent mutagenic TLS during DNA damaging chemotherapy can help overcome problems due to both intrinsic resistance and acquired resistance. Ways to develop drugs that block mutagenic TLS are also considered, including taking advantage of structural knowledge to target key protein-protein interfaces.</p>
</sec>
<sec id="sec002" sec-type="intro">
<title>Introduction</title>
<p>While DNA damaging chemotherapy can be very effective and even curative in the treatment of certain cancers, intrinsic and acquired drug resistance underlies tumor progression and morbidity in many cancer patients. Intrinsic resistance defines a cell state that is inherently tolerant of drug action. This can include the activation of drug efflux pumps or detoxifying processes that effectively reduce intracellular drug concentration [<xref ref-type="bibr" rid="pgen.1006842.ref001">1</xref>]. This can also include a change in the recognition or persistence of DNA damage, mediated by an enhanced DNA repair capability, a blunted DNA damage response, or the ability to proliferate in the presence of DNA damage. Conversely, acquired drug resistance represents a mutational or epigenetic process by which a chemosensitive cell develops 1 or more of the characteristics of an intrinsically resistant cancer cell. Thus, the mechanisms underlying intrinsic and acquired drug resistance are quite distinct. One describes a cell state, and the other describes the capability of reaching that cell state. Yet, these processes are very much coupled in the context of mutagenic translesion synthesis (TLS).</p>
<p>As discussed throughout this review, mutagenic TLS polymerases underlie 2 important phenotypes in response to genotoxic chemotherapy. First, they allow for the bypass of modified DNA bases during DNA synthesis, allowing proliferation to continue in the presence of chemotherapy. Second, the low fidelity replication performed by TLS polymerases results in the introduction of inappropriate, nonpairing bases across from modified nucleotides. The bypass function of TLS polymerases is particularly relevant to intrinsic drug resistance. Many tumors, including most pancreatic adenocarcinomas, nonsmall cell lung cancers, and aggressive brain tumors, as well as most metastatic malignancies, fail to significantly regress following chemotherapy [<xref ref-type="bibr" rid="pgen.1006842.ref002">2</xref>]. In these tumors, TLS activity contributes to a drug resistant state by promoting the tolerance of DNA damage [<xref ref-type="bibr" rid="pgen.1006842.ref003">3</xref>–<xref ref-type="bibr" rid="pgen.1006842.ref006">6</xref>]. Conversely, the mutational role of TLS polymerases is central to process of acquired drug resistance. Tumor regression and relapse following chemotherapy is almost always accompanied by the development of drug resistant disease. This may not occur at initial relapse, but upon serial cycles of treatment patients generally succumb to tumors that have acquired intrinsically resistant disease. In fact, for certain cancers the overall prognosis is not dictated by the initial response of the tumor to chemotherapy. Rather, the response of the relapsed tumor to therapy is a significantly better determinant of overall survival. For instance, a high error-prone TLS activity translates into greater tumor adaptation to chemotherapy, while a low error-prone TLS activity leaves tumor in a treatment-naïve state. This latter state is amenable to continued long-term treatment of tumors that remain response to treatment with the initial therapy.</p>
<p>The dual functions of mutagenic TLS polymerases in intrinsic and acquired chemoresistance make these proteins very attractive potential targets for adjuvant therapy. When combined with front-line genotoxic therapy, these TLS inhibitors would be expected to sensitize tumors to chemotherapy while blocking drug-induced mutation. Consequently, while the generation of such inhibitors is complex, their route to the clinic is more apparent. TLS inhibitors could be applied in combination with the standard of care for many malignancies. By effectively increasing the effects of chemotherapy in target cells, these agents may also allow for a reduction in chemotherapy dose regimens. An added benefit of these agents may be a reduction in the rate of secondary chemotherapy-driven malignancies that occur in patients following successful treatment of the primary disease.</p>
</sec>
<sec id="sec003">
<title>TLS polymerases bypass DNA damage</title>
<p>TLS polymerases are highly conserved, specialized DNA polymerases that can replicate past aberrant DNA lesions but in a lower fidelity manner—a trade-off that preserves genomic integrity in cells [<xref ref-type="bibr" rid="pgen.1006842.ref007">7</xref>]. These incorrect nucleotides become fixed into mutations during the next round of DNA replication, contributing to overall fitness and evolution in single cell organisms but propelling tumorigenesis and disease in humans (<xref ref-type="fig" rid="pgen.1006842.g001">Fig 1A</xref>). There are 10 known human TLS polymerases (REV1, POL η, POL ι, POL κ, POL ζ, POL μ, POL λ, POL β, POL ν, and POL θ), which are distributed in 4 families (Y, B, X, and A), and also Prim Pol, which additionally has primase activity. Although all TLS DNA polymerases are more error-prone than replicative DNA polymerases, some are capable of bypassing specific (cognate) lesions in a relatively error-free manner (<xref ref-type="table" rid="pgen.1006842.t001">Table 1</xref>). The extent of DNA synthesis errors during TLS depends on various factors, including the identities of the TLS polymerases employed, the presence or absence of cognate lesions, DNA sequence context, and thermodynamic favorability in the catalytic step [<xref ref-type="bibr" rid="pgen.1006842.ref008">8</xref>–<xref ref-type="bibr" rid="pgen.1006842.ref010">10</xref>]. The significance of the TLS process to human health is illustrated by xeroderma pigmentosum-variant patients, who are deficient in POL η and are therefore susceptible to UV radiation-induced cancers because the cognate UV-induced cyclobutane pyrimidine dimers are instead bypassed by alternate TLS polymerases (POL ι and POL κ) in a relatively error-prone manner [<xref ref-type="bibr" rid="pgen.1006842.ref011">11</xref>, <xref ref-type="bibr" rid="pgen.1006842.ref012">12</xref>].</p>
<fig id="pgen.1006842.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1006842.g001</object-id>
<label>Fig 1</label>
<caption>
<title>DNA damage bypass process.</title>
<p>(A) Mechanism of the 2-step DNA damage bypass process. To bypass DNA damage, REV1 inserts deoxycytidine triphosphates across the damage or orchestrates the recruitment of the other polymerases, POL ι, POL κ, POL η, to replicate across the damage. Thereafter, POL ζ complex can help extend beyond the damage to enable re-initiation of undamaged DNA replication. If an incorrect nucleotide gets incorporated across the damage, this misincorporated nucleotide will lead to a mutation in the next round of replication. (B) A schematic representing the protein domains of the Y-family translesion synthesis (TLS) polymerases, REV1, POL ι, POL κ, POL η.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.1006842.g001" xlink:type="simple"/>
</fig>
<table-wrap id="pgen.1006842.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1006842.t001</object-id>
<label>Table 1</label> <caption><title>Summary of the characteristics, expression, the availability of mouse model, and association to cancers of B- and Y-family translesion synthesis polymerases.</title></caption>
<alternatives>
<graphic id="pgen.1006842.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.1006842.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center">Polymerase</th>
<th align="center">Characteristics</th>
<th align="center">Expression</th>
<th align="center">Mice Model</th>
<th align="center">Cancer Association</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">REV1 (<italic>REV1)</italic><break/>Y-family<break/></td>
<td align="left">• Exclusively inserts dCMPs opposite template Gs, abasic sites, and adducted G residues [<xref ref-type="bibr" rid="pgen.1006842.ref013">13</xref>, <xref ref-type="bibr" rid="pgen.1006842.ref014">14</xref>]<break/>• Acts as a scaffolding protein by interacting with both POL ζ and RIR containing POL η, POL κ and POL ι [<xref ref-type="bibr" rid="pgen.1006842.ref015">15</xref>, <xref ref-type="bibr" rid="pgen.1006842.ref016">16</xref>]<break/>• Generates G/C substitutions during Ig gene somatic hypermutation [<xref ref-type="bibr" rid="pgen.1006842.ref017">17</xref>]<break/>• Accumulates in DNA damaged induced foci [<xref ref-type="bibr" rid="pgen.1006842.ref018">18</xref>–<xref ref-type="bibr" rid="pgen.1006842.ref020">20</xref>]</td>
<td align="left">• Protein expression is cytoplasmic in all tissues, with highest in adrenal gland, muscle, liver, etc. (<ext-link ext-link-type="uri" xlink:href="http://www.proteinatlas.org/ENSG00000135945-REV1/tissue" xlink:type="simple">http://www.proteinatlas.org/ENSG00000135945-REV1/tissue</ext-link>)<break/>• RNA expressed in all tissues, with highest expression in brain tissues and reproductive organs (<ext-link ext-link-type="uri" xlink:href="http://www.proteinatlas.org/ENSG00000135945-REV1/tissue" xlink:type="simple">http://www.proteinatlas.org/ENSG00000135945-REV1/tissue</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://gtexportal.org/home/gene/REV1" xlink:type="simple">https://gtexportal.org/home/gene/REV1</ext-link>)</td>
<td align="left">• <italic>Rev1</italic><sup>BRCT</sup> (ΔBRCT region; accelerated skin cancers, genotoxin-induced genome instability) [<xref ref-type="bibr" rid="pgen.1006842.ref021">21</xref>, <xref ref-type="bibr" rid="pgen.1006842.ref022">22</xref>].<break/>• <italic>Rev1</italic><sup>AA</sup> (defective Rev1 catalytic domain; reduced somatic hypermutation) [<xref ref-type="bibr" rid="pgen.1006842.ref023">23</xref>].<break/>• <italic>Rev1</italic><sup>KO</sup> (Rev1 deficient; near-infertile and unstable genome) [<xref ref-type="bibr" rid="pgen.1006842.ref024">24</xref>]</td>
<td align="left">• Several hepatocarcinomas and occasional lung cancers show high expression of REV1 [<xref ref-type="bibr" rid="pgen.1006842.ref025">25</xref>] (<ext-link ext-link-type="uri" xlink:href="http://www.proteinatlas.org/ENSG00000135945-REV1/cancer" xlink:type="simple">http://www.proteinatlas.org/ENSG00000135945-REV1/cancer</ext-link>) <break/>• Responsible for drug resistance in ovarian cancer cells [<xref ref-type="bibr" rid="pgen.1006842.ref026">26</xref>]<break/>• No known somatic mutations in cancers</td>
</tr>
<tr>
<td align="left">POL η (<italic>POLH</italic>)<break/>Y-family</td>
<td align="left">• Bypasses T-T CPD and cisplatin-GG efficiently, but inefficiently across adducted residues, AP sites, 8-oxo-G [<xref ref-type="bibr" rid="pgen.1006842.ref027">27</xref>–<xref ref-type="bibr" rid="pgen.1006842.ref032">32</xref>]<break/>• Accumulates at DNA damage foci [<xref ref-type="bibr" rid="pgen.1006842.ref020">20</xref>, <xref ref-type="bibr" rid="pgen.1006842.ref033">33</xref>].<break/>• Generates A/T substitutions during somatic hypermutagenesis [<xref ref-type="bibr" rid="pgen.1006842.ref034">34</xref>]</td>
<td align="left">• Protein expression ubiquitous in nucleus and cytoplasm of all tissues, with high expression in thyroid, lung, pancreas, placenta, testis, etc. (<ext-link ext-link-type="uri" xlink:href="http://www.proteinatlas.org/ENSG00000170734-POLH/tissue" xlink:type="simple">http://www.proteinatlas.org/ENSG00000170734-POLH/tissue</ext-link>) <break/>• RNA expressed in all tissues, with highest expression in tonsil, lymph nodes and testis (<ext-link ext-link-type="uri" xlink:href="http://www.proteinatlas.org/ENSG00000170734-POLH/tissue" xlink:type="simple">http://www.proteinatlas.org/ENSG00000170734-POLH/tissue</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://gtexportal.org/home/gene/POLH" xlink:type="simple">https://gtexportal.org/home/gene/POLH</ext-link>)</td>
<td align="left">• <italic>Polh</italic><sup>KO</sup> (Pol η deficient; fertile, viable, but susceptible to skin cancers, mirrors XP-V phenotype, UV irradiated cells prone to chromatid breaks) [<xref ref-type="bibr" rid="pgen.1006842.ref035">35</xref>–<xref ref-type="bibr" rid="pgen.1006842.ref037">37</xref>]<break/>• <italic>Polh</italic><sup>+/-</sup> (slightly susceptible to UV radiation-induced skin carcinogenesis) [<xref ref-type="bibr" rid="pgen.1006842.ref035">35</xref>]<break/></td>
<td align="left">• Gene mutations causes XP-V [<xref ref-type="bibr" rid="pgen.1006842.ref038">38</xref>]<break/>• High expression in single basal cell carcinomas of the skin and some liver cancers (<ext-link ext-link-type="uri" xlink:href="http://www.proteinatlas.org/ENSG00000170734-POLH/cancer" xlink:type="simple">http://www.proteinatlas.org/ENSG00000170734-POLH/cancer</ext-link>) <break/>• Enhanced expression in ovarian cancer stem cells [<xref ref-type="bibr" rid="pgen.1006842.ref039">39</xref>]<break/>• Elevated levels in head and neck tumor samples [<xref ref-type="bibr" rid="pgen.1006842.ref040">40</xref>]<break/>• 3 missense <italic>POLH</italic> mutations found amongst 201 melanoma patients [<xref ref-type="bibr" rid="pgen.1006842.ref041">41</xref>]</td>
</tr>
<tr>
<td align="left">POL κ (<italic>POLK</italic>)<break/>Y-family</td>
<td align="left">• Propensity to make −1 frameshift mutations, but efficiently bypasses thymine glycols and guanine adducts [<xref ref-type="bibr" rid="pgen.1006842.ref042">42</xref>, <xref ref-type="bibr" rid="pgen.1006842.ref043">43</xref>]<break/>• Propensity to extend mispaired primer-template termini [<xref ref-type="bibr" rid="pgen.1006842.ref044">44</xref>]</td>
<td align="left">• Protein expression data in normal tissues unknown<break/>• RNA expressed in all tissues, with slightly high expression in thyroid, parathyroid, endometrium, and testis (<ext-link ext-link-type="uri" xlink:href="http://www.proteinatlas.org/ENSG00000122008-POLK/tissue#gene_information" xlink:type="simple">http://www.proteinatlas.org/ENSG00000122008-POLK/tissue#gene_information</ext-link> &amp; <ext-link ext-link-type="uri" xlink:href="https://gtexportal.org/home/gene/POLK" xlink:type="simple">https://gtexportal.org/home/gene/POLK</ext-link>)</td>
<td align="left"><italic>Polk</italic><sup>KO</sup> (Pol κ deficient; fertile, cells are UV sensitive, spontaneous mutator phenotype in kidneys, liver and lungs, and the mice has shortened survival than <italic>Polk</italic><sup>+/-</sup> and <italic>Polk</italic><sup>+/+</sup> mice) [<xref ref-type="bibr" rid="pgen.1006842.ref045">45</xref>, <xref ref-type="bibr" rid="pgen.1006842.ref046">46</xref>]</td>
<td align="left">• Elevated expression in lung cancer [<xref ref-type="bibr" rid="pgen.1006842.ref047">47</xref>, <xref ref-type="bibr" rid="pgen.1006842.ref048">48</xref>]<break/>• Ectopic overexpression of POL κ induces aneuploidy and carcinogenesis in mice [<xref ref-type="bibr" rid="pgen.1006842.ref049">49</xref>]<break/>• Two non-coding <italic>POLK</italic> SNPs associated with lung cancer risk [<xref ref-type="bibr" rid="pgen.1006842.ref050">50</xref>]<break/>• Three somatic <italic>POLK</italic> mutations in 26 prostrate patients [<xref ref-type="bibr" rid="pgen.1006842.ref051">51</xref>]</td>
</tr>
<tr>
<td align="left">POL ι (<italic>POLI</italic>)<break/>Y-family</td>
<td align="left">• Efficiently bypasses template dA; but does so inefficiently on the template dT [<xref ref-type="bibr" rid="pgen.1006842.ref052">52</xref>, <xref ref-type="bibr" rid="pgen.1006842.ref053">53</xref>]<break/>• Briefly accumulates in replication stress foci [<xref ref-type="bibr" rid="pgen.1006842.ref054">54</xref>]<break/>• Back-up polymerase in the absence of POL η. Inefficiently bypasses UV damage in the absence of POL η [<xref ref-type="bibr" rid="pgen.1006842.ref011">11</xref>, <xref ref-type="bibr" rid="pgen.1006842.ref055">55</xref>]</td>
<td align="left">• High protein expression in parathyroid, thyroid, reproductive organs and pituitary (<ext-link ext-link-type="uri" xlink:href="http://www.proteinatlas.org/ENSG00000101751-POLI/tissue" xlink:type="simple">http://www.proteinatlas.org/ENSG00000101751-POLI/tissue</ext-link>) <break/>• High RNA expression in testis, thyroid and parathyroid gland (<ext-link ext-link-type="uri" xlink:href="http://www.proteinatlas.org/ENSG00000101751-POLI/tissue" xlink:type="simple">http://www.proteinatlas.org/ENSG00000101751-POLI/tissue</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://gtexportal.org/home/gene/POLI" xlink:type="simple">https://gtexportal.org/home/gene/POLI</ext-link>)</td>
<td align="left"><italic>Poli</italic><sup>KO</sup> (Pol ι deficient; mice susceptible to damage-induced lung tumors) [<xref ref-type="bibr" rid="pgen.1006842.ref056">56</xref>].<break/><italic>Polι</italic><sup>KO</sup> mice cells not sensitive to DNA damaging agents [<xref ref-type="bibr" rid="pgen.1006842.ref057">57</xref>]</td>
<td align="left">• Elevated expression in breast cancer cells [<xref ref-type="bibr" rid="pgen.1006842.ref058">58</xref>]<break/>• Important candidate for lung neoplasia [<xref ref-type="bibr" rid="pgen.1006842.ref059">59</xref>]<break/>• Overexpressed in bladder cancer and in esophageal squamous cell carcinoma [<xref ref-type="bibr" rid="pgen.1006842.ref060">60</xref>–<xref ref-type="bibr" rid="pgen.1006842.ref062">62</xref>]<break/>• <italic>POLI</italic> SNP (rs8305) correlated with significant high risk of both lung adenocarcinoma and squamous cell carcinoma [<xref ref-type="bibr" rid="pgen.1006842.ref063">63</xref>]<break/>• <italic>POLI</italic> SNP (rs3218786) significantly associated with TMPRSS2-ERG fusion-positive prostrate tumors [<xref ref-type="bibr" rid="pgen.1006842.ref064">64</xref>]</td>
</tr>
<tr>
<td align="left">POL ζ<sub>4</sub><break/>B-family<break/>(REV3 [<italic>REV3</italic>] polymerase, REV7 [<italic>REV7</italic>], POLD2 and POLD3 accessory subunits) [<xref ref-type="bibr" rid="pgen.1006842.ref065">65</xref>]<break/></td>
<td align="left">• POL ζ<sub>4</sub> mediate inefficient TLS across CPDs, (6–4) photoproducts, adducted residues and AP sites, but an error free bypass of thymine glycols [<xref ref-type="bibr" rid="pgen.1006842.ref053">53</xref>, <xref ref-type="bibr" rid="pgen.1006842.ref066">66</xref>, <xref ref-type="bibr" rid="pgen.1006842.ref067">67</xref>]<break/>• Serves as the key extender polymerase during TLS [<xref ref-type="bibr" rid="pgen.1006842.ref068">68</xref>]</td>
<td align="left">• REV3 protein is expressed minimally in the cytoplasm of different tissue types. REV3L transcript is highly expressed in endometrin, smooth muscle, cerebellum and the uterine tissues (<ext-link ext-link-type="uri" xlink:href="http://www.proteinatlas.org/ENSG00000009413-REV3L/tissue" xlink:type="simple">http://www.proteinatlas.org/ENSG00000009413-REV3L/tissue</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://gtexportal.org/home/gene/REV3" xlink:type="simple">https://gtexportal.org/home/gene/REV3</ext-link>) <break/>• High REV7 protein expression in bone marrow and lung tissues. And high REV7 RNA expression in testis, bone marrow, lymph nodes, tonsils, and appendix (<ext-link ext-link-type="uri" xlink:href="http://www.proteinatlas.org/ENSG00000116670-MAD2L2/tissue" xlink:type="simple">http://www.proteinatlas.org/ENSG00000116670-MAD2L2/tissue</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://gtexportal.org/home/gene/MAD2L" xlink:type="simple">https://gtexportal.org/home/gene/MAD2L</ext-link>)</td>
<td align="left">• <italic>Rev3</italic><sup>KO</sup> (Rev3 deficient; embryonically lethal and spontaneous and genotoxin induced genome instability) [<xref ref-type="bibr" rid="pgen.1006842.ref069">69</xref>–<xref ref-type="bibr" rid="pgen.1006842.ref071">71</xref>]<break/>• <italic>Rev3</italic><sup>Δlox</sup> (conditional Rev3 deficiency; reduced cell proliferation, spontaneous genomic instability and mice develop spontaneously mic lymphoma and spontaneous skin tumors) [<xref ref-type="bibr" rid="pgen.1006842.ref072">72</xref>–<xref ref-type="bibr" rid="pgen.1006842.ref074">74</xref>]<break/>• <italic>Rev7</italic><sup>KO</sup> (Rev7 deficient; delayed growth, infertile, reduced cell proliferation, spontaneous genome instability) [<xref ref-type="bibr" rid="pgen.1006842.ref075">75</xref>, <xref ref-type="bibr" rid="pgen.1006842.ref076">76</xref>]</td>
<td align="left">• REV7 depletion enhances cisplatin sensitivity in ovarian cancer cells [<xref ref-type="bibr" rid="pgen.1006842.ref077">77</xref>]<break/>• Loss of REV7 sensitizes ovarian and breast cancer cells to PARP inhibition [<xref ref-type="bibr" rid="pgen.1006842.ref078">78</xref>]<break/>• High expression in B-cell lymphoma [<xref ref-type="bibr" rid="pgen.1006842.ref079">79</xref>]<break/>• Elevated expression in colon cancer [<xref ref-type="bibr" rid="pgen.1006842.ref080">80</xref>]<break/></td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>AP, apurinic; CPD, cyclobutane pyrimidine dimers; dCMP, deoxycytidine monophosphate; TLS, translesion synthesis; XP-V, xeroderma pigmentosum-variant.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Distinct structural and biochemical features of the TLS polymerases enable them to replicate past the DNA damage. For example, in contrast to classical replicative polymerases, Y-family TLS polymerases possess a smaller thumb and finger domain that makes fewer contacts with DNA and also lack an 3ʹ-5ʹ exonuclease activity to proofread misincorporated nucleotides. Together, these structural attributes result in a larger and/or more permissive catalytic site than replicative polymerases that allows TLS polymerases to accommodate distorted and damaged nucleotides [<xref ref-type="bibr" rid="pgen.1006842.ref081">81</xref>, <xref ref-type="bibr" rid="pgen.1006842.ref082">82</xref>]. In addition, other physical features such as the polymerase-associated domain of Y-family polymerases and the wrist and the N-clasp region of POL κ also contribute to polymerase architecture conducive to replication across DNA damage (<xref ref-type="fig" rid="pgen.1006842.g001">Fig 1B</xref>) [<xref ref-type="bibr" rid="pgen.1006842.ref083">83</xref>–<xref ref-type="bibr" rid="pgen.1006842.ref087">87</xref>]. Furthermore, regulatory domains of TLS polymerases enable their proper localization and regulation [<xref ref-type="bibr" rid="pgen.1006842.ref088">88</xref>]. These special structural features of TLS polymerases are fundamental to their roles in DNA damage bypass.</p>
<p>Besides the structural features of individual TLS polymerases, successful TLS also depends on interactions between these polymerases and other cellular proteins that target and choreograph their activity. REV1 functions as a principle scaffolding protein, which recruits other TLS polymerases to first insert a nucleotide opposite the DNA lesion and then eventually help extend the distorted primer-template terminus, in what is recognized as the two-step mechanism of TLS (<xref ref-type="fig" rid="pgen.1006842.g002">Fig 2</xref>) [<xref ref-type="bibr" rid="pgen.1006842.ref007">7</xref>, <xref ref-type="bibr" rid="pgen.1006842.ref008">8</xref>, <xref ref-type="bibr" rid="pgen.1006842.ref089">89</xref>]. For the insertion step, a particular interface of the REV1 CTD interacts with the REV1-interacting-region (RIR) of the inserter polymerases (POL η, POL ι, POL κ). Mutations that disrupt the RIR-interface in the Rev1 CTD prevent interaction with the inserter polymerase in yeast-2 hybrid (Y2H) screens [<xref ref-type="bibr" rid="pgen.1006842.ref015">15</xref>, <xref ref-type="bibr" rid="pgen.1006842.ref016">16</xref>, <xref ref-type="bibr" rid="pgen.1006842.ref090">90</xref>, <xref ref-type="bibr" rid="pgen.1006842.ref091">91</xref>]. Insertion across from the damaged base can also be less frequently carried out by REV1 and POL ζ [<xref ref-type="bibr" rid="pgen.1006842.ref008">8</xref>]. In the second step, an extender TLS enzyme, a role most frequently fulfilled by POL ζ (REV3/REV7/POLD2/POLD3) and in some cases by POL κ, replaces the inserter and extends the primer-template termini [<xref ref-type="bibr" rid="pgen.1006842.ref090">90</xref>]. For the POL ζ -mediated extension step, a different interface in REV1 CTD—distinct from the interface for RIR recognition—makes contact with specific amino acids located on REV7. Mutating residues in the Rev7-interface of the Rev1 CTD inhibits Rev1-Rev7 interaction in Y2H studies and sensitizes chicken DT40 cells to cisplatin [<xref ref-type="bibr" rid="pgen.1006842.ref015">15</xref>]. Apart from bypassing DNA damage at stalled replication forks, TLS polymerases also engage in filling single stranded (ss) DNA gaps left behind by replicative polymerases, via the less-well understood gap-filling mechanism [<xref ref-type="bibr" rid="pgen.1006842.ref092">92</xref>, <xref ref-type="bibr" rid="pgen.1006842.ref093">93</xref>].</p>
<fig id="pgen.1006842.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1006842.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Protein-protein interactions between translesion synthesis (TLS) polymerases are important for the DNA damage bypass process.</title>
<p>Two pathways are expected to facilitate TLS across DNA damage—the REV1 dependent and REV1 independent pathway. Majority of the DNA lesions are bypassed in a REV1 dependent fashion, which engages in protein-protein interactions with other TLS polymerases via its C-terminus. REV1 interacts with the REV1-interacting-region (RIR)-containing residues of POL ι, POL κ, POL η to enable insertion of nucleotides across the damage. And REV1 also interacts via key residues with REV7 of the POL ζ complex to facilitate extension beyond the insertion step. REV1 also binds to POLD3 subunit of the POL ζ complex to enable the key switch from the “insertion” to the “extension” step. In the REV1 independent pathway, the RIR-containing polymerases, POL ι, POL κ, POL η, by interacting with the proliferating cell nuclear antigen (PCNA) interacting protein (PIP) and ubiquitin-binding motif (UBM)/ ubiquitin-binding zinc finger (UBZ) domains of PCNA, can also enable TLS at the damaged site. Likewise, the POL ζ complex also interacts with the PIP box of PCNA to access the DNA and enable TLS.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.1006842.g002" xlink:type="simple"/>
</fig>
<p>Interestingly, TLS polymerases are also required for other cellular functions. For example, during interstrand cross-link (ICL) repair in replicating cells, certain TLS polymerases—REV1, POL ι, POL κ and POL ν—are required for DNA synthesis over the ICL on the newly exposed leading strand [<xref ref-type="bibr" rid="pgen.1006842.ref094">94</xref>–<xref ref-type="bibr" rid="pgen.1006842.ref097">97</xref>]. Likewise, in nonreplicating cells, ICL repair depends on the Rev1-POL ζ TLS polymerases to fill the ssDNA-gaps [<xref ref-type="bibr" rid="pgen.1006842.ref098">98</xref>]. In a similar fashion, both nucleotide excision repair (NER) and base excision repair (BER) pathways respectively can employ POL κ and POL η to fill the ssDNA gaps left behind after the excising step [<xref ref-type="bibr" rid="pgen.1006842.ref099">99</xref>, <xref ref-type="bibr" rid="pgen.1006842.ref100">100</xref>]. Additionally, POL η was recently shown to drive microhomology-mediated break-induced replication (MMBIR) that causes complex genomic rearrangements in yeast and has an important role in homologous recombination (HR) in DT40 cells [<xref ref-type="bibr" rid="pgen.1006842.ref101">101</xref>, <xref ref-type="bibr" rid="pgen.1006842.ref102">102</xref>]. Finally, REV1 was recently shown to be required for replication of G-quadruplex structures, thereby influencing epigenetic stability [<xref ref-type="bibr" rid="pgen.1006842.ref103">103</xref>]. Independent of its role in TLS, REV7 promotes nonhomologous end joining (NHEJ) at double strand breaks and at telomeres by inhibiting CtIP-mediated end resection [<xref ref-type="bibr" rid="pgen.1006842.ref104">104</xref>]. Additionally, REV7 plays a supporting role in cell cycle regulation by sequestering CDH1, which prevents premature activation of the anaphase-promoting complex, thereby inhibiting an exit from mitosis [<xref ref-type="bibr" rid="pgen.1006842.ref105">105</xref>]. All these examples are suggestive of an overarching influence of TLS polymerases and their components on cellular physiology, in which they influence DNA damage tolerance, DNA repair, epigenetic stability, and replication across repetitive sequences.</p>
</sec>
<sec id="sec004">
<title>Modulation of TLS polymerases alters tumor response to chemotherapy</title>
<p>A growing body of evidence now shows that suppression of TLS polymerases not only sensitizes tumor cells to drugs, but also reduces acquisition of drug-induced mutations implicated in tumor resistance. Thus, inhibition of TLS polymerases is a promising new approach to improving cancer therapy. Moreover, in some cancers, TLS polymerases are overexpressed (<xref ref-type="table" rid="pgen.1006842.t001">Table 1</xref>),</p>
<p>The impact TLS polymerases have on chemotherapy responses in different cancer subtypes has recently been investigated. In one study, the potential of Rev3 inhibition for the treatment of intrinsically chemoresistant cancers was investigated. A study utilizing the <italic>Kras</italic><sup><italic>G12D</italic></sup><italic>;p53</italic><sup><italic>−/−</italic></sup> preclinical model of lung adenocarcinoma showed that, when the level of Rev3 was reduced, these otherwise resistant tumors were sensitized to cisplatin, increasing the overall survival of mice with Rev3-deficient tumors by 2-fold compared with control mice with Rev3-proficient tumors [<xref ref-type="bibr" rid="pgen.1006842.ref106">106</xref>]. Reduction of Rev3 or Rev1 in these tumor cells also reduced cisplatin-induced mutagenesis in culture.</p>
<p>In a study that employed the <italic>Eμ-myc arf</italic><sup>-/-</sup> mouse model of B-cell lymphoma, when mice were subjected to repeated cycles of tumor engraftment and cyclophosphamide treatment, relapsed tumors that appeared after the first round of chemotherapy continued to respond to cyclophosphamide if they were Rev1 deficient. This is in direct contrast to Rev1-proficient relapsed tumors, which exhibited varying degrees of acquired resistance to cyclophosphamide chemotherapy (<xref ref-type="fig" rid="pgen.1006842.g003">Fig 3</xref>). Additionally, cyclophosphamide-induced mutagenesis of these lymphoma cells in culture was suppressed by Rev1 depletion. These studies showed that Rev1-dependent error-prone bypass of cyclophosphamide-induced DNA damage contributes to the mutagenesis and hence the tumor drug resistance. Thus this study provided the first in vivo evidence that TLS polymerases play a critical role in the development of acquired chemoresistance [<xref ref-type="bibr" rid="pgen.1006842.ref107">107</xref>].</p>
<fig id="pgen.1006842.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1006842.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Reduction of Rev1 suppresses chemoresistance.</title>
<p>In a tumor mouse model, administration of chemotherapy reduces tumor formation by killing the generally chemoresensitive tumor cells. However, many of the tumors that relapse are resistant to further killing from chemotherapeutic treatment, thereby reducing survival of the mice. In contrast, mice harboring relapsed tumors in which REV1 has been knocked down remain sensitive to chemotherapy, whereby their survival is prolonged.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.1006842.g003" xlink:type="simple"/>
</fig>
<p>Chemotherapy-induced mutagenesis is a phenomenon proposed to cause secondary malignancies and tumor relapse. Hence, targeting REV1 and REV3 might not only increase killing of cancer cells but could also potentially suppress secondary malignancies and tumor relapse. The same principal was explored when an innovative nanoparticle-mediated delivery system was used to target both REV1 and REV3 in combination with a cisplatin prodrug. A nearly complete inhibition of tumor growth and dramatically enhanced survival was observed in LnCaP prostate cancer mouse model [<xref ref-type="bibr" rid="pgen.1006842.ref108">108</xref>]. In addition, REV7 depletion has been shown to sensitize ovarian cancer to cisplatin and reduce tumor volumes in nude mice [<xref ref-type="bibr" rid="pgen.1006842.ref077">77</xref>]. These studies support the hypothesis that TLS inhibition can suppress at least some classes of intrinsic chemoresistance. Likewise depletion of REV3 in cervical cancer cells [<xref ref-type="bibr" rid="pgen.1006842.ref109">109</xref>] or nonsmall cell lung cancer cells [<xref ref-type="bibr" rid="pgen.1006842.ref110">110</xref>]; REV1, POL ζ, POL η in HeLa cells [<xref ref-type="bibr" rid="pgen.1006842.ref111">111</xref>]; and POL η in ovarian cancer stem cells [<xref ref-type="bibr" rid="pgen.1006842.ref039">39</xref>] all sensitize cells to cisplatin. It remains to be seen whether other cancer cell subtypes would similarly respond to knockdown of TLS polymerases and whether observations in cell studies could be recapitulated in mouse models.</p>
<p>Another approach to potentially enhance tumor cell killing via suppression of TLS polymerases is to discover synthetic lethal partners of TLS polymerases. For example, this classical approach is employed in killing BRCA2-deficient tumors by utilizing PARP1 inhibitors [<xref ref-type="bibr" rid="pgen.1006842.ref112">112</xref>]. Although a compelling idea, TLS synthetic partners are largely unknown. However, a whole genome siRNA library screen in A549 lung cancer cells identified one gene RRMI—the large subunit of ribonucleotide reductase that confers a synthetic lethal interaction with REV3 [<xref ref-type="bibr" rid="pgen.1006842.ref113">113</xref>]. In another lung cancer cell line and in breast cancer cells, ataxia-telangiectasia and Rad3 related inhibition was found to synthetically enhance lethality in cisplatin-treated REV3-deficient cells [<xref ref-type="bibr" rid="pgen.1006842.ref114">114</xref>]. In addition, Rev3-deficient DT40 cells exhibited synthetic lethality with RAD54 [<xref ref-type="bibr" rid="pgen.1006842.ref115">115</xref>], suggesting a promising potential. Synthetic-lethal partners of TLS polymerases need to be explored in greater detail across other cancer subtypes.</p>
</sec>
<sec id="sec005">
<title>Drug inhibitors to target TLS polymerases</title>
<p>Taken together, the studies discussed above suggest that small molecules that directly inhibit catalytic functions or disrupt key protein-protein interactions of TLS polymerases could be adjuvants that have the potential to significantly improve chemotherapy. For example, fluorescence-based assays conducted in high-throughput platforms were used to search for small molecule inhibitors that affect catalytic functions of TLS polymerases. Pamoic acid, aurintricarboxylic acid, and ellagic acid were found to inhibit POL ι and POL η [<xref ref-type="bibr" rid="pgen.1006842.ref112">112</xref>], while candesartan cilexetil inhibited the enzymatic function of POL κ as well as enhanced UV-induced cytotoxicity in xeroderma pigmentosum-variant (XP-V) cells [<xref ref-type="bibr" rid="pgen.1006842.ref116">116</xref>]. Likewise, 3-<italic>O</italic>-methylfunicone, a natural compound isolated from a marine fungal strain, selectively inhibited mammalian Y-family TLS polymerase activity (POL κ, POL, ι, POL η) [<xref ref-type="bibr" rid="pgen.1006842.ref117">117</xref>]. Further studies are required to identify compounds with improved specificity and potency.</p>
<p>Very recently small molecules inhibitors that target TLS DNA polymerase protein-protein interactions have been shown to be possible therapeutic candidates. For example, a small molecule inhibitor that binds to REV7 and inhibits its interaction with REV3 was shown to partially suppress ICL repair [<xref ref-type="bibr" rid="pgen.1006842.ref118">118</xref>]. Whether the same drug could also suppress TLS is worth investigating. Similarly, detailed structural knowledge of other TLS interfaces, such as between REV1 and REV7 and between REV1 and RIR carrying proteins could be exploited in drug discovery and design.</p>
</sec>
<sec id="sec006">
<title>Perspective and conclusion</title>
<p>Inhibiting TLS polymerases is a promising approach to improve chemotherapy as it could increase killing of cancer cells, while at the same time reducing the possibility of relapse and acquired drug resistance by reducing chemotherapy-induced mutagenesis. Even cancers known to be intrinsically drug resistant could potentially be sensitized by this approach. Additionally, TLS specific inhibition could also potentially target other repair and recombination pathways that involve TLS polymerases including NER, BER, MMBIR, HR, and NHEJ. However, several outstanding questions still need to be addressed, for example, improving understanding of the structural basis of key protein-protein interactions made by the TLS polymerases. Recently it was shown that the subunits of replicative polymerases cross talk with TLS Polymerases. For instance, the POLD3 subunit of the replicative DNA polymerase POL δ possess an RIR that interacts with the RIR-interface of REV1 CTD, while the POLD2 subunit of POL δ interacts with POL η [<xref ref-type="bibr" rid="pgen.1006842.ref090">90</xref>]. These observations suggest that the TLS mechanism is even more complex than previously anticipated and that drug inhibitors for 1 TLS polymerase could potentially target multiple other TLS polymerases. An added complication is that TLS polymerases η, ι, and κ can also function independently of REV1 by interacting with proliferating cell nuclear antigen (PCNA) via the UBM/UBZ domain and the PCNA interacting protein (PIP) domain (<xref ref-type="fig" rid="pgen.1006842.g002">Fig 2</xref>). It is not known quantitatively what percent of DNA damage in the cells is bypassed in a Rev1-dependent versus REV1-independent manner. This knowledge will help decipher whether a single inhibitor targeting the Rev1/RIR or the REV1/REV7 interaction or a combination of inhibitors targeting the REV1/RIR, REV1/Rev7 and UBM/UBZ-PIP-PCNA interactions would be required for a complete TLS inhibition. Also, a better understanding of synthetic lethal partners of TLS polymerases would provide insights into which tumors might be most susceptible to chemotherapy treatments involving small molecule inhibitors of TLS polymerases. Finally, the effectiveness of small molecule inhibitors of TLS polymerase could be further improved by delivery systems that could target these drugs to specific tumors in cancer patients. Because protein-protein interactions are so important for TLS, drug targets for these interaction interfaces could be promising candidates for cancer therapeutics.</p>
</sec>
</body>
<back>
<ack>
<p>We thank members of the Walker lab for valuable comments.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pgen.1006842.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zahreddine</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Borden</surname> <given-names>KLB</given-names></name>. <article-title>Mechanisms and insights into drug resistance in cancer</article-title>. <source>Front Pharmacol</source>. <year>2013</year>;<volume>4</volume>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2013.00028" xlink:type="simple">10.3389/fphar.2013.00028</ext-link></comment> <object-id pub-id-type="pmid">23504227</object-id></mixed-citation></ref>
<ref id="pgen.1006842.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Neesse</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Michl</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Frese</surname> <given-names>KK</given-names></name>, <name name-style="western"><surname>Feig</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Cook</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Jacobetz</surname> <given-names>MA</given-names></name>, <etal>et al</etal>. <article-title>Stromal biology and therapy in pancreatic cancer</article-title>. <source>Gut</source>. <year>2011</year>;<volume>60</volume>(<issue>6</issue>):<fpage>861</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/gut.2010.226092" xlink:type="simple">10.1136/gut.2010.226092</ext-link></comment> <object-id pub-id-type="pmid">20966025</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Knobel</surname> <given-names>PA</given-names></name>, <name name-style="western"><surname>Marti</surname> <given-names>TM</given-names></name>. <article-title>Translesion DNA synthesis in the context of cancer research</article-title>. <source>Cancer Cell Int</source>. <year>2011</year>;<volume>11</volume>:<fpage>39</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1475-2867-11-39" xlink:type="simple">10.1186/1475-2867-11-39</ext-link></comment> <object-id pub-id-type="pmid">22047021</object-id>; PubMed Central PMCID: PMCPMC3224763.</mixed-citation></ref>
<ref id="pgen.1006842.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>He</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Mao</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Dai</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Association of polymorphisms in translesion synthesis genes with prognosis of advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy</article-title>. <source>J Surg Oncol</source>. <year>2016</year>;<volume>113</volume>(<issue>1</issue>):<fpage>17</fpage>–<lpage>23</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/jso.24103" xlink:type="simple">10.1002/jso.24103</ext-link></comment> <object-id pub-id-type="pmid">26611653</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>HW</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>X</given-names></name>, <etal>et al</etal>. <article-title>Analysis of specialized DNA polymerases expression in human gliomas: association with prognostic significance</article-title>. <source>Neuro Oncol</source>. <year>2010</year>;<volume>12</volume>(<issue>7</issue>):<fpage>679</fpage>–<lpage>86</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/neuonc/nop074" xlink:type="simple">10.1093/neuonc/nop074</ext-link></comment> <object-id pub-id-type="pmid">20164241</object-id>; PubMed Central PMCID: PMCPMC2940659.</mixed-citation></ref>
<ref id="pgen.1006842.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Broustas</surname> <given-names>CG</given-names></name>, <name name-style="western"><surname>Lieberman</surname> <given-names>HB</given-names></name>. <article-title>DNA damage response genes and the development of cancer metastasis</article-title>. <source>Radiat Res</source>. <year>2014</year>;<volume>181</volume>(<issue>2</issue>):<fpage>111</fpage>–<lpage>30</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1667/RR13515.1" xlink:type="simple">10.1667/RR13515.1</ext-link></comment> <object-id pub-id-type="pmid">24397478</object-id>; PubMed Central PMCID: PMCPMC4064942.</mixed-citation></ref>
<ref id="pgen.1006842.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sale</surname> <given-names>J.E.</given-names></name> <name name-style="western"><surname>LARa</surname> <given-names>RW</given-names></name>. <article-title>Y-family DNA polymerases and their role in tolerance of cellular DNA damage</article-title>. <source>Nat Rev Mol Cell Biol</source>. <year>2013</year>;<volume>13</volume>(<issue>3</issue>):<fpage>141</fpage>–<lpage>52</lpage>.</mixed-citation></ref>
<ref id="pgen.1006842.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Waters</surname> <given-names>LS</given-names></name>, <name name-style="western"><surname>Minesinger</surname> <given-names>BK</given-names></name>, <name name-style="western"><surname>Wiltrout</surname> <given-names>ME</given-names></name>, <name name-style="western"><surname>D'Souza</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Woodruff</surname> <given-names>RV</given-names></name>, <name name-style="western"><surname>Walker</surname> <given-names>GC</given-names></name>. <article-title>Eukaryotic translesion polymerases and their roles and regulation in DNA damage tolerance</article-title>. <source>Microbiol Mol Biol Rev</source>. <year>2009</year>;<volume>73</volume>(<issue>1</issue>):<fpage>134</fpage>–<lpage>54</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/MMBR.00034-08" xlink:type="simple">10.1128/MMBR.00034-08</ext-link></comment> <object-id pub-id-type="pmid">19258535</object-id>; PubMed Central PMCID: PMCPMC2650891.</mixed-citation></ref>
<ref id="pgen.1006842.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pages</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Fuchs</surname> <given-names>RP</given-names></name>. <article-title>How DNA lesions are turned into mutations within cells?</article-title> <source>Oncogene</source>. <year>2002</year>;<volume>21</volume>(<issue>58</issue>):<fpage>8957</fpage>–<lpage>66</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/sj.onc.1206006" xlink:type="simple">10.1038/sj.onc.1206006</ext-link></comment> <object-id pub-id-type="pmid">12483512</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McCulloch</surname> <given-names>SD</given-names></name>, <name name-style="western"><surname>Kokoska</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>Kunkel</surname> <given-names>TA</given-names></name>. <article-title>Efficiency, fidelity and enzymatic switching during translesion DNA synthesis</article-title>. <source>Cell Cycle</source>. <year>2004</year>;<volume>3</volume>(<issue>5</issue>):<fpage>580</fpage>–<lpage>3</lpage>. <object-id pub-id-type="pmid">15118407</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Woodgate</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>McManus</surname> <given-names>TP</given-names></name>, <name name-style="western"><surname>Mead</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>McCormick</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Maher</surname> <given-names>VM</given-names></name>. <article-title>Evidence that in xeroderma pigmentosum variant cells, which lack DNA polymerase eta, DNA polymerase iota causes the very high frequency and unique spectrum of UV-induced mutations</article-title>. <source>Cancer Res</source>. <year>2007</year>;<volume>67</volume>(<issue>7</issue>):<fpage>3018</fpage>–<lpage>26</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/0008-5472.CAN-06-3073" xlink:type="simple">10.1158/0008-5472.CAN-06-3073</ext-link></comment> <object-id pub-id-type="pmid">17409408</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ziv</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Geacintov</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Nakajima</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Yasui</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Livneh</surname> <given-names>Z</given-names></name>. <article-title>DNA polymerase zeta cooperates with polymerases kappa and iota in translesion DNA synthesis across pyrimidine photodimers in cells from XPV patients</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2009</year>;<volume>106</volume>(<issue>28</issue>):<fpage>11552</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.0812548106" xlink:type="simple">10.1073/pnas.0812548106</ext-link></comment> <object-id pub-id-type="pmid">19564618</object-id>; PubMed Central PMCID: PMCPMC2710681.</mixed-citation></ref>
<ref id="pgen.1006842.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nelson</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Lawrence</surname> <given-names>CW</given-names></name>, <name name-style="western"><surname>Hinkle</surname> <given-names>DC</given-names></name>. <article-title>Deoxycytidyl transferase activity of yeast REV1 protein</article-title>. <source>Nature</source>. <year>1996</year>;<volume>382</volume>(<issue>6593</issue>):<fpage>729</fpage>–<lpage>31</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/382729a0" xlink:type="simple">10.1038/382729a0</ext-link></comment> <object-id pub-id-type="pmid">8751446</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Washington</surname> <given-names>MT</given-names></name>, <name name-style="western"><surname>Minko</surname> <given-names>IG</given-names></name>, <name name-style="western"><surname>Johnson</surname> <given-names>RE</given-names></name>, <name name-style="western"><surname>Haracska</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Harris</surname> <given-names>TM</given-names></name>, <name name-style="western"><surname>Lloyd</surname> <given-names>RS</given-names></name>, <etal>et al</etal>. <article-title>Efficient and error-free replication past a minor-groove N2-guanine adduct by the sequential action of yeast Rev1 and DNA polymerase zeta</article-title>. <source>Mol Cell Biol</source>. <year>2004</year>;<volume>24</volume>(<issue>16</issue>):<fpage>6900</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/MCB.24.16.6900-6906.2004" xlink:type="simple">10.1128/MCB.24.16.6900-6906.2004</ext-link></comment> <object-id pub-id-type="pmid">15282292</object-id>; PubMed Central PMCID: PMCPMC479736.</mixed-citation></ref>
<ref id="pgen.1006842.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wojtaszek</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>CJ</given-names></name>, <name name-style="western"><surname>D'Souza</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Minesinger</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>D'Andrea</surname> <given-names>AD</given-names></name>, <etal>et al</etal>. <article-title>Structural basis of Rev1-mediated assembly of a quaternary vertebrate translesion polymerase complex consisting of Rev1, heterodimeric polymerase (Pol) zeta, and Pol kappa</article-title>. <source>J Biol Chem</source>. <year>2012</year>;<volume>287</volume>(<issue>40</issue>):<fpage>33836</fpage>–<lpage>46</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M112.394841" xlink:type="simple">10.1074/jbc.M112.394841</ext-link></comment> <object-id pub-id-type="pmid">22859295</object-id>; PubMed Central PMCID: PMCPMC3460478.</mixed-citation></ref>
<ref id="pgen.1006842.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wojtaszek</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>D'Souza</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Xue</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Walker</surname> <given-names>GC</given-names></name>, <etal>et al</etal>. <article-title>Multifaceted recognition of vertebrate Rev1 by translesion polymerases zeta and kappa</article-title>. <source>J Biol Chem</source>. <year>2012</year>;<volume>287</volume>(<issue>31</issue>):<fpage>26400</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M112.380998" xlink:type="simple">10.1074/jbc.M112.380998</ext-link></comment> <object-id pub-id-type="pmid">22700975</object-id>; PubMed Central PMCID: PMCPMC3406723.</mixed-citation></ref>
<ref id="pgen.1006842.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Simpson</surname> <given-names>LJ</given-names></name>, <name name-style="western"><surname>Sale</surname> <given-names>JE</given-names></name>. <article-title>Rev1 is essential for DNA damage tolerance and non-templated immunoglobulin gene mutation in a vertebrate cell line</article-title>. <source>EMBO J</source>. <year>2003</year>;<volume>22</volume>(<issue>7</issue>):<fpage>1654</fpage>–<lpage>64</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/emboj/cdg161" xlink:type="simple">10.1093/emboj/cdg161</ext-link></comment> <object-id pub-id-type="pmid">12660171</object-id>; PubMed Central PMCID: PMCPMC152905.</mixed-citation></ref>
<ref id="pgen.1006842.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mukhopadhyay</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Clark</surname> <given-names>DR</given-names></name>, <name name-style="western"><surname>Watson</surname> <given-names>NB</given-names></name>, <name name-style="western"><surname>Zacharias</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>McGregor</surname> <given-names>WG</given-names></name>. <article-title>REV1 accumulates in DNA damage-induced nuclear foci in human cells and is implicated in mutagenesis by benzo[a]pyrenediolepoxide</article-title>. <source>Nucleic Acids Res</source>. <year>2004</year>;<volume>32</volume>(<issue>19</issue>):<fpage>5820</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gkh903" xlink:type="simple">10.1093/nar/gkh903</ext-link></comment> <object-id pub-id-type="pmid">15523096</object-id>; PubMed Central PMCID: PMCPMC528789.</mixed-citation></ref>
<ref id="pgen.1006842.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Dejsuphong</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>D'Andrea</surname> <given-names>AD</given-names></name>. <article-title>Regulation of Rev1 by the Fanconi anemia core complex</article-title>. <source>Nat Struct Mol Biol</source>. <year>2012</year>;<volume>19</volume>(<issue>2</issue>):<fpage>164</fpage>–<lpage>70</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nsmb.2222" xlink:type="simple">10.1038/nsmb.2222</ext-link></comment> <object-id pub-id-type="pmid">22266823</object-id>; PubMed Central PMCID: PMCPMC3280818.</mixed-citation></ref>
<ref id="pgen.1006842.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tissier</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Kannouche</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Reck</surname> <given-names>MP</given-names></name>, <name name-style="western"><surname>Lehmann</surname> <given-names>AR</given-names></name>, <name name-style="western"><surname>Fuchs</surname> <given-names>RP</given-names></name>, <name name-style="western"><surname>Cordonnier</surname> <given-names>A</given-names></name>. <article-title>Co-localization in replication foci and interaction of human Y-family members, DNA polymerase pol eta and REVl protein</article-title>. <source>DNA Repair (Amst)</source>. <year>2004</year>;<volume>3</volume>(<issue>11</issue>):<fpage>1503</fpage>–<lpage>14</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.dnarep.2004.06.015" xlink:type="simple">10.1016/j.dnarep.2004.06.015</ext-link></comment> <object-id pub-id-type="pmid">15380106</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jansen</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>Tsaalbi-Shtylik</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Langerak</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Calleja</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Meijers</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>Jacobs</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>The BRCT domain of mammalian Rev1 is involved in regulating DNA translesion synthesis</article-title>. <source>Nucleic Acids Res</source>. <year>2005</year>;<volume>33</volume>(<issue>1</issue>):<fpage>356</fpage>–<lpage>65</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gki189" xlink:type="simple">10.1093/nar/gki189</ext-link></comment> <object-id pub-id-type="pmid">15653636</object-id>; PubMed Central PMCID: PMCPMC546167.</mixed-citation></ref>
<ref id="pgen.1006842.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tsaalbi-Shtylik</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Verspuy</surname> <given-names>JW</given-names></name>, <name name-style="western"><surname>Jansen</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>Rebel</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Carlee</surname> <given-names>LM</given-names></name>, <name name-style="western"><surname>van der Valk</surname> <given-names>MA</given-names></name>, <etal>et al</etal>. <article-title>Error-prone translesion replication of damaged DNA suppresses skin carcinogenesis by controlling inflammatory hyperplasia</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2009</year>;<volume>106</volume>(<issue>51</issue>):<fpage>21836</fpage>–<lpage>41</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.0909507106" xlink:type="simple">10.1073/pnas.0909507106</ext-link></comment> <object-id pub-id-type="pmid">20007784</object-id>; PubMed Central PMCID: PMCPMC2799833.</mixed-citation></ref>
<ref id="pgen.1006842.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Masuda</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Ouchida</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Gao</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Mori</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>JY</given-names></name>. <article-title>A critical role for REV1 in regulating the induction of C:G transitions and A:T mutations during Ig gene hypermutation</article-title>. <source>J Immunol</source>. <year>2009</year>;<volume>183</volume>(<issue>3</issue>):<fpage>1846</fpage>–<lpage>50</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4049/jimmunol.0901240" xlink:type="simple">10.4049/jimmunol.0901240</ext-link></comment> <object-id pub-id-type="pmid">19587019</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Krijger</surname> <given-names>PH</given-names></name>, <name name-style="western"><surname>Tsaalbi-Shtylik</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Wit</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>van den Berk</surname> <given-names>PC</given-names></name>, <name name-style="western"><surname>de Wind</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Jacobs</surname> <given-names>H</given-names></name>. <article-title>Rev1 is essential in generating G to C transversions downstream of the Ung2 pathway but not the Msh2+Ung2 hybrid pathway</article-title>. <source>Eur J Immunol</source>. <year>2013</year>;<volume>43</volume>(<issue>10</issue>):<fpage>2765</fpage>–<lpage>70</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/eji.201243191" xlink:type="simple">10.1002/eji.201243191</ext-link></comment> <object-id pub-id-type="pmid">23857323</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dumstorf</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Mukhopadhyay</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Krishnan</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Haribabu</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>McGregor</surname> <given-names>WG</given-names></name>. <article-title>REV1 is implicated in the development of carcinogen-induced lung cancer</article-title>. <source>Mol Cancer Res</source>. <year>2009</year>;<volume>7</volume>(<issue>2</issue>):<fpage>247</fpage>–<lpage>54</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/1541-7786.MCR-08-0399" xlink:type="simple">10.1158/1541-7786.MCR-08-0399</ext-link></comment> <object-id pub-id-type="pmid">19176310</object-id>; PubMed Central PMCID: PMCPMC2644734.</mixed-citation></ref>
<ref id="pgen.1006842.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lin</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Okuda</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Trang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Howell</surname> <given-names>SB</given-names></name>. <article-title>Human REV1 modulates the cytotoxicity and mutagenicity of cisplatin in human ovarian carcinoma cells</article-title>. <source>Mol Pharmacol</source>. <year>2006</year>;<volume>69</volume>(<issue>5</issue>):<fpage>1748</fpage>–<lpage>54</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1124/mol.105.020446" xlink:type="simple">10.1124/mol.105.020446</ext-link></comment> <object-id pub-id-type="pmid">16495473</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Klarer</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>Stallons</surname> <given-names>LJ</given-names></name>, <name name-style="western"><surname>Burke</surname> <given-names>TJ</given-names></name>, <name name-style="western"><surname>Skaggs</surname> <given-names>RL</given-names></name>, <name name-style="western"><surname>McGregor</surname> <given-names>WG</given-names></name>. <article-title>DNA polymerase eta participates in the mutagenic bypass of adducts induced by benzo[a]pyrene diol epoxide in mammalian cells</article-title>. <source>PLoS ONE</source>. <year>2012</year>;<volume>7</volume>(<issue>6</issue>):<fpage>e39596</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0039596" xlink:type="simple">10.1371/journal.pone.0039596</ext-link></comment> <object-id pub-id-type="pmid">22745795</object-id>; PubMed Central PMCID: PMCPMC3380003.</mixed-citation></ref>
<ref id="pgen.1006842.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stary</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Kannouche</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Lehmann</surname> <given-names>AR</given-names></name>, <name name-style="western"><surname>Sarasin</surname> <given-names>A</given-names></name>. <article-title>Role of DNA polymerase eta in the UV mutation spectrum in human cells</article-title>. <source>J Biol Chem</source>. <year>2003</year>;<volume>278</volume>(<issue>21</issue>):<fpage>18767</fpage>–<lpage>75</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M211838200" xlink:type="simple">10.1074/jbc.M211838200</ext-link></comment> <object-id pub-id-type="pmid">12644471</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Maga</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Villani</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Crespan</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Wimmer</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Ferrari</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Bertocci</surname> <given-names>B</given-names></name>, <etal>et al</etal>. <article-title>8-oxo-guanine bypass by human DNA polymerases in the presence of auxiliary proteins</article-title>. <source>Nature</source>. <year>2007</year>;<volume>447</volume>(<issue>7144</issue>):<fpage>606</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature05843" xlink:type="simple">10.1038/nature05843</ext-link></comment> <object-id pub-id-type="pmid">17507928</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hendel</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ziv</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Gueranger</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Geacintov</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Livneh</surname> <given-names>Z</given-names></name>. <article-title>Reduced efficiency and increased mutagenicity of translesion DNA synthesis across a TT cyclobutane pyrimidine dimer, but not a TT 6–4 photoproduct, in human cells lacking DNA polymerase eta</article-title>. <source>DNA Repair (Amst)</source>. <year>2008</year>;<volume>7</volume>(<issue>10</issue>):<fpage>1636</fpage>–<lpage>46</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.dnarep.2008.06.008" xlink:type="simple">10.1016/j.dnarep.2008.06.008</ext-link></comment> <object-id pub-id-type="pmid">18634905</object-id>; PubMed Central PMCID: PMCPMC2656611.</mixed-citation></ref>
<ref id="pgen.1006842.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Masutani</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Kusumoto</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Iwai</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Hanaoka</surname> <given-names>F</given-names></name>. <article-title>Mechanisms of accurate translesion synthesis by human DNA polymerase eta</article-title>. <source>EMBO J</source>. <year>2000</year>;<volume>19</volume>(<issue>12</issue>):<fpage>3100</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/emboj/19.12.3100" xlink:type="simple">10.1093/emboj/19.12.3100</ext-link></comment> <object-id pub-id-type="pmid">10856253</object-id>; PubMed Central PMCID: PMCPMC203367.</mixed-citation></ref>
<ref id="pgen.1006842.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhao</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Biertumpfel</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Gregory</surname> <given-names>MT</given-names></name>, <name name-style="western"><surname>Hua</surname> <given-names>YJ</given-names></name>, <name name-style="western"><surname>Hanaoka</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>W</given-names></name>. <article-title>Structural basis of human DNA polymerase eta-mediated chemoresistance to cisplatin</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2012</year>;<volume>109</volume>(<issue>19</issue>):<fpage>7269</fpage>–<lpage>74</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1202681109" xlink:type="simple">10.1073/pnas.1202681109</ext-link></comment> <object-id pub-id-type="pmid">22529383</object-id>; PubMed Central PMCID: PMCPMC3358888.</mixed-citation></ref>
<ref id="pgen.1006842.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Solovjeva</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Svetlova</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sasina</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Tanaka</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Saijo</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Nazarov</surname> <given-names>I</given-names></name>, <etal>et al</etal>. <article-title>High mobility of flap endonuclease 1 and DNA polymerase eta associated with replication foci in mammalian S-phase nucleus</article-title>. <source>Mol Biol Cell</source>. <year>2005</year>;<volume>16</volume>(<issue>5</issue>):<fpage>2518</fpage>–<lpage>28</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1091/mbc.E04-12-1066" xlink:type="simple">10.1091/mbc.E04-12-1066</ext-link></comment> <object-id pub-id-type="pmid">15758026</object-id>; PubMed Central PMCID: PMCPMC1087254.</mixed-citation></ref>
<ref id="pgen.1006842.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zeng</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Winter</surname> <given-names>DB</given-names></name>, <name name-style="western"><surname>Kasmer</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Kraemer</surname> <given-names>KH</given-names></name>, <name name-style="western"><surname>Lehmann</surname> <given-names>AR</given-names></name>, <name name-style="western"><surname>Gearhart</surname> <given-names>PJ</given-names></name>. <article-title>DNA polymerase eta is an A-T mutator in somatic hypermutation of immunoglobulin variable genes</article-title>. <source>Nat Immunol</source>. <year>2001</year>;<volume>2</volume>(<issue>6</issue>):<fpage>537</fpage>–<lpage>41</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/88740" xlink:type="simple">10.1038/88740</ext-link></comment> <object-id pub-id-type="pmid">11376341</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lin</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Clark</surname> <given-names>AB</given-names></name>, <name name-style="western"><surname>McCulloch</surname> <given-names>SD</given-names></name>, <name name-style="western"><surname>Yuan</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Bronson</surname> <given-names>RT</given-names></name>, <name name-style="western"><surname>Kunkel</surname> <given-names>TA</given-names></name>, <etal>et al</etal>. <article-title>Increased susceptibility to UV-induced skin carcinogenesis in polymerase eta-deficient mice</article-title>. <source>Cancer Res</source>. <year>2006</year>;<volume>66</volume>(<issue>1</issue>):<fpage>87</fpage>–<lpage>94</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/0008-5472.CAN-05-1862" xlink:type="simple">10.1158/0008-5472.CAN-05-1862</ext-link></comment> <object-id pub-id-type="pmid">16397220</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rey</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Sidorova</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Puget</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Boudsocq</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Biard</surname> <given-names>DS</given-names></name>, <name name-style="western"><surname>Monnat</surname> <given-names>RJ</given-names> <suffix>Jr</suffix></name>, <etal>et al</etal>. <article-title>Human DNA polymerase eta is required for common fragile site stability during unperturbed DNA replication</article-title>. <source>Mol Cell Biol</source>. <year>2009</year>;<volume>29</volume>(<issue>12</issue>):<fpage>3344</fpage>–<lpage>54</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/MCB.00115-09" xlink:type="simple">10.1128/MCB.00115-09</ext-link></comment> <object-id pub-id-type="pmid">19380493</object-id>; PubMed Central PMCID: PMCPMC2698728.</mixed-citation></ref>
<ref id="pgen.1006842.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ito</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Yokoi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sakayoshi</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Sakurai</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Akagi</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Mitani</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Stalled Poleta at its cognate substrate initiates an alternative translesion synthesis pathway via interaction with REV1</article-title>. <source>Genes Cells</source>. <year>2012</year>;<volume>17</volume>(<issue>2</issue>):<fpage>98</fpage>–<lpage>108</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1365-2443.2011.01576.x" xlink:type="simple">10.1111/j.1365-2443.2011.01576.x</ext-link></comment> <object-id pub-id-type="pmid">22244149</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Masutani</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Kusumoto</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Yamada</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Dohmae</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Yokoi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Yuasa</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta</article-title>. <source>Nature</source>. <year>1999</year>;<volume>399</volume>(<issue>6737</issue>):<fpage>700</fpage>–<lpage>4</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/21447" xlink:type="simple">10.1038/21447</ext-link></comment> <object-id pub-id-type="pmid">10385124</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Srivastava</surname> <given-names>AK</given-names></name>, <name name-style="western"><surname>Han</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Zhao</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Cui</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Dai</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Mao</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Enhanced expression of DNA polymerase eta contributes to cisplatin resistance of ovarian cancer stem cells</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2015</year>;<volume>112</volume>(<issue>14</issue>):<fpage>4411</fpage>–<lpage>6</lpage>. Epub 2015/04/02. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1421365112" xlink:type="simple">10.1073/pnas.1421365112</ext-link></comment> <object-id pub-id-type="pmid">25831546</object-id>; PubMed Central PMCID: PMC4394248.</mixed-citation></ref>
<ref id="pgen.1006842.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhou</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>YW</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Chu</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Loria</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Expression of DNA translesion synthesis polymerase eta in head and neck squamous cell cancer predicts resistance to gemcitabine and cisplatin-based chemotherapy</article-title>. <source>PLoS ONE</source>. <year>2013</year>;<volume>8</volume>(<issue>12</issue>):<fpage>e83978</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0083978" xlink:type="simple">10.1371/journal.pone.0083978</ext-link></comment> <object-id pub-id-type="pmid">24376779</object-id>; PubMed Central PMCID: PMCPMC3869838.</mixed-citation></ref>
<ref id="pgen.1006842.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Di Lucca</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Guedj</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Lacapere</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Fargnoli</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>Bourillon</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Dieude</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Variants of the xeroderma pigmentosum variant gene (POLH) are associated with melanoma risk</article-title>. <source>Eur J Cancer</source>. <year>2009</year>;<volume>45</volume>(<issue>18</issue>):<fpage>3228</fpage>–<lpage>36</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ejca.2009.04.034" xlink:type="simple">10.1016/j.ejca.2009.04.034</ext-link></comment> <object-id pub-id-type="pmid">19477635</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ogi</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Kato</surname> <given-names>T</given-names> <suffix>Jr.</suffix></name>, <name name-style="western"><surname>Kato</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Ohmori</surname> <given-names>H</given-names></name>. <article-title>Mutation enhancement by DINB1, a mammalian homologue of the Escherichia coli mutagenesis protein dinB</article-title>. <source>Genes Cells</source>. <year>1999</year>;<volume>4</volume>(<issue>11</issue>):<fpage>607</fpage>–<lpage>18</lpage>. <object-id pub-id-type="pmid">10620008</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Choi</surname> <given-names>JY</given-names></name>, <name name-style="western"><surname>Angel</surname> <given-names>KC</given-names></name>, <name name-style="western"><surname>Guengerich</surname> <given-names>FP</given-names></name>. <article-title>Translesion synthesis across bulky N2-alkyl guanine DNA adducts by human DNA polymerase kappa</article-title>. <source>J Biol Chem</source>. <year>2006</year>;<volume>281</volume>(<issue>30</issue>):<fpage>21062</fpage>–<lpage>72</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M602246200" xlink:type="simple">10.1074/jbc.M602246200</ext-link></comment> <object-id pub-id-type="pmid">16751196</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Washington</surname> <given-names>MT</given-names></name>, <name name-style="western"><surname>Johnson</surname> <given-names>RE</given-names></name>, <name name-style="western"><surname>Prakash</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Prakash</surname> <given-names>S</given-names></name>. <article-title>Human DINB1-encoded DNA polymerase kappa is a promiscuous extender of mispaired primer termini</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2002</year>;<volume>99</volume>(<issue>4</issue>):<fpage>1910</fpage>–<lpage>4</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.032594399" xlink:type="simple">10.1073/pnas.032594399</ext-link></comment> <object-id pub-id-type="pmid">11842189</object-id>; PubMed Central PMCID: PMCPMC122293.</mixed-citation></ref>
<ref id="pgen.1006842.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schenten</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Gerlach</surname> <given-names>VL</given-names></name>, <name name-style="western"><surname>Guo</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Velasco-Miguel</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Hladik</surname> <given-names>CL</given-names></name>, <name name-style="western"><surname>White</surname> <given-names>CL</given-names></name>, <etal>et al</etal>. <article-title>DNA polymerase kappa deficiency does not affect somatic hypermutation in mice</article-title>. <source>Eur J Immunol</source>. <year>2002</year>;<volume>32</volume>(<issue>11</issue>):<fpage>3152</fpage>–<lpage>60</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/1521-4141(200211)32:11&lt;3152::AID-IMMU3152&gt;3.0.CO;2-2" xlink:type="simple">10.1002/1521-4141(200211)32:11&lt;3152::AID-IMMU3152&gt;3.0.CO;2-2</ext-link></comment> <object-id pub-id-type="pmid">12555660</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stancel</surname> <given-names>JN</given-names></name>, <name name-style="western"><surname>McDaniel</surname> <given-names>LD</given-names></name>, <name name-style="western"><surname>Velasco</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Richardson</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Guo</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Friedberg</surname> <given-names>EC</given-names></name>. <article-title>Polk mutant mice have a spontaneous mutator phenotype</article-title>. <source>DNA Repair (Amst)</source>. <year>2009</year>;<volume>8</volume>(<issue>12</issue>):<fpage>1355</fpage>–<lpage>62</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.dnarep.2009.09.003" xlink:type="simple">10.1016/j.dnarep.2009.09.003</ext-link></comment> <object-id pub-id-type="pmid">19783230</object-id>; PubMed Central PMCID: PMCPMC2787749.</mixed-citation></ref>
<ref id="pgen.1006842.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Seimiya</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kawamura</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Yu</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Ogi</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Takenaga</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Elevated expression of DNA polymerase kappa in human lung cancer is associated with p53 inactivation: Negative regulation of POLK promoter activity by p53</article-title>. <source>Int J Oncol</source>. <year>2004</year>;<volume>25</volume>(<issue>1</issue>):<fpage>161</fpage>–<lpage>5</lpage>. <object-id pub-id-type="pmid">15202001</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>J</surname> <given-names>OW</given-names></name>, <name name-style="western"><surname>Kawamura</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Tada</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Ohmori</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Kimura</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Sakiyama</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>DNA polymerase kappa, implicated in spontaneous and DNA damage-induced mutagenesis, is overexpressed in lung cancer</article-title>. <source>Cancer Res</source>. <year>2001</year>;<volume>61</volume>(<issue>14</issue>):<fpage>5366</fpage>–<lpage>9</lpage>. <object-id pub-id-type="pmid">11454676</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref049"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bavoux</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Leopoldino</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Bergoglio</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>J</surname> <given-names>OW</given-names></name>, <name name-style="western"><surname>Ogi</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Bieth</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Up-regulation of the error-prone DNA polymerase {kappa} promotes pleiotropic genetic alterations and tumorigenesis</article-title>. <source>Cancer Res</source>. <year>2005</year>;<volume>65</volume>(<issue>1</issue>):<fpage>325</fpage>–<lpage>30</lpage>. <object-id pub-id-type="pmid">15665310</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref050"><label>50</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Michiels</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Danoy</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Dessen</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Bera</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Boulet</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Bouchardy</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Polymorphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers</article-title>. <source>Carcinogenesis</source>. <year>2007</year>;<volume>28</volume>(<issue>8</issue>):<fpage>1731</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/carcin/bgm111" xlink:type="simple">10.1093/carcin/bgm111</ext-link></comment> <object-id pub-id-type="pmid">17494052</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref051"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Makridakis</surname> <given-names>NM</given-names></name>, <name name-style="western"><surname>Phipps</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Srivastav</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Reichardt</surname> <given-names>JK</given-names></name>. <article-title>PCR-free method detects high frequency of genomic instability in prostate cancer</article-title>. <source>Nucleic Acids Res</source>. <year>2009</year>;<volume>37</volume>(<issue>22</issue>):<fpage>7441</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gkp761" xlink:type="simple">10.1093/nar/gkp761</ext-link></comment> <object-id pub-id-type="pmid">19797393</object-id>; PubMed Central PMCID: PMCPMC2794161.</mixed-citation></ref>
<ref id="pgen.1006842.ref052"><label>52</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Choi</surname> <given-names>JY</given-names></name>, <name name-style="western"><surname>Lim</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Eoff</surname> <given-names>RL</given-names></name>, <name name-style="western"><surname>Guengerich</surname> <given-names>FP</given-names></name>. <article-title>Kinetic analysis of base-pairing preference for nucleotide incorporation opposite template pyrimidines by human DNA polymerase iota</article-title>. <source>J Mol Biol</source>. <year>2009</year>;<volume>389</volume>(<issue>2</issue>):<fpage>264</fpage>–<lpage>74</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jmb.2009.04.023" xlink:type="simple">10.1016/j.jmb.2009.04.023</ext-link></comment> <object-id pub-id-type="pmid">19376129</object-id>; PubMed Central PMCID: PMCPMC4010588.</mixed-citation></ref>
<ref id="pgen.1006842.ref053"><label>53</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Johnson</surname> <given-names>RE</given-names></name>, <name name-style="western"><surname>Washington</surname> <given-names>MT</given-names></name>, <name name-style="western"><surname>Haracska</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Prakash</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Prakash</surname> <given-names>L</given-names></name>. <article-title>Eukaryotic polymerases iota and zeta act sequentially to bypass DNA lesions</article-title>. <source>Nature</source>. <year>2000</year>;<volume>406</volume>(<issue>6799</issue>):<fpage>1015</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/35023030" xlink:type="simple">10.1038/35023030</ext-link></comment> <object-id pub-id-type="pmid">10984059</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref054"><label>54</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kannouche</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Fernandez de Henestrosa</surname> <given-names>AR</given-names></name>, <name name-style="western"><surname>Coull</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Vidal</surname> <given-names>AE</given-names></name>, <name name-style="western"><surname>Gray</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Zicha</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Localization of DNA polymerases eta and iota to the replication machinery is tightly co-ordinated in human cells</article-title>. <source>EMBO J</source>. <year>2002</year>;<volume>21</volume>(<issue>22</issue>):<fpage>6246</fpage>–<lpage>56</lpage>. <object-id pub-id-type="pmid">12426396</object-id>; PubMed Central PMCID: PMCPMC137208. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/emboj/cdf618" xlink:type="simple">10.1093/emboj/cdf618</ext-link></comment></mixed-citation></ref>
<ref id="pgen.1006842.ref055"><label>55</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dumstorf</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Clark</surname> <given-names>AB</given-names></name>, <name name-style="western"><surname>Lin</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Kissling</surname> <given-names>GE</given-names></name>, <name name-style="western"><surname>Yuan</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Kucherlapati</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Participation of mouse DNA polymerase iota in strand-biased mutagenic bypass of UV photoproducts and suppression of skin cancer</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2006</year>;<volume>103</volume>(<issue>48</issue>):<fpage>18083</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.0605247103" xlink:type="simple">10.1073/pnas.0605247103</ext-link></comment> <object-id pub-id-type="pmid">17114294</object-id>; PubMed Central PMCID: PMCPMC1838710.</mixed-citation></ref>
<ref id="pgen.1006842.ref056"><label>56</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname> <given-names>GH</given-names></name>, <name name-style="western"><surname>Matsushita</surname> <given-names>H</given-names></name>. <article-title>Genetic linkage between Pol iota deficiency and increased susceptibility to lung tumors in mice</article-title>. <source>Cancer Sci</source>. <year>2005</year>;<volume>96</volume>(<issue>5</issue>):<fpage>256</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1349-7006.2005.00042.x" xlink:type="simple">10.1111/j.1349-7006.2005.00042.x</ext-link></comment> <object-id pub-id-type="pmid">15904465</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref057"><label>57</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ohkumo</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Kondo</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Yokoi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Tsukamoto</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Yamada</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Sugimoto</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>UV-B radiation induces epithelial tumors in mice lacking DNA polymerase eta and mesenchymal tumors in mice deficient for DNA polymerase iota</article-title>. <source>Mol Cell Biol</source>. <year>2006</year>;<volume>26</volume>(<issue>20</issue>):<fpage>7696</fpage>–<lpage>706</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/MCB.01076-06" xlink:type="simple">10.1128/MCB.01076-06</ext-link></comment> <object-id pub-id-type="pmid">17015482</object-id>; PubMed Central PMCID: PMCPMC1636855.</mixed-citation></ref>
<ref id="pgen.1006842.ref058"><label>58</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Hickey</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>Malkas</surname> <given-names>LH</given-names></name>. <article-title>Altered DNA polymerase iota expression in breast cancer cells leads to a reduction in DNA replication fidelity and a higher rate of mutagenesis</article-title>. <source>Cancer Res</source>. <year>2004</year>;<volume>64</volume>(<issue>16</issue>):<fpage>5597</fpage>–<lpage>607</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/0008-5472.CAN-04-0603" xlink:type="simple">10.1158/0008-5472.CAN-04-0603</ext-link></comment> <object-id pub-id-type="pmid">15313897</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref059"><label>59</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Devereux</surname> <given-names>TR</given-names></name>, <name name-style="western"><surname>Vikis</surname> <given-names>HG</given-names></name>, <name name-style="western"><surname>McCulloch</surname> <given-names>SD</given-names></name>, <name name-style="western"><surname>Holliday</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Anna</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Pol iota is a candidate for the mouse pulmonary adenoma resistance 2 locus, a major modifier of chemically induced lung neoplasia</article-title>. <source>Cancer Res</source>. <year>2004</year>;<volume>64</volume>(<issue>6</issue>):<fpage>1924</fpage>–<lpage>31</lpage>. <object-id pub-id-type="pmid">15026325</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref060"><label>60</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yuan</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Xu</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Wei</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Yu</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Overexpressed DNA polymerase iota regulated by JNK/c-Jun contributes to hypermutagenesis in bladder cancer</article-title>. <source>PLoS ONE</source>. <year>2013</year>;<volume>8</volume>(<issue>7</issue>):<fpage>e69317</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0069317" xlink:type="simple">10.1371/journal.pone.0069317</ext-link></comment> <object-id pub-id-type="pmid">23922701</object-id>; PubMed Central PMCID: PMCPMC3724822.</mixed-citation></ref>
<ref id="pgen.1006842.ref061"><label>61</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhou</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Xie</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Xie</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Overexpression of DNA polymerase iota (Poliota) in esophageal squamous cell carcinoma</article-title>. <source>Cancer Sci</source>. <year>2012</year>;<volume>103</volume>(<issue>8</issue>):<fpage>1574</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1349-7006.2012.02309.x" xlink:type="simple">10.1111/j.1349-7006.2012.02309.x</ext-link></comment> <object-id pub-id-type="pmid">22509890</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref062"><label>62</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zou</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Shang</surname> <given-names>ZF</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>DNA polymerase iota (Pol iota) promotes invasion and metastasis of esophageal squamous cell carcinoma</article-title>. <source>Oncotarget</source>. <year>2016</year>;<volume>7</volume>(<issue>22</issue>):<fpage>32274</fpage>–<lpage>85</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.8580" xlink:type="simple">10.18632/oncotarget.8580</ext-link></comment> <object-id pub-id-type="pmid">27057634</object-id>; PubMed Central PMCID: PMCPMC5078012.</mixed-citation></ref>
<ref id="pgen.1006842.ref063"><label>63</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sakiyama</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Kohno</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Mimaki</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Ohta</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Yanagitani</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Sobue</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk</article-title>. <source>Int J Cancer</source>. <year>2005</year>;<volume>114</volume>(<issue>5</issue>):<fpage>730</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ijc.20790" xlink:type="simple">10.1002/ijc.20790</ext-link></comment> <object-id pub-id-type="pmid">15609317</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref064"><label>64</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Luedeke</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Linnert</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>Hofer</surname> <given-names>MD</given-names></name>, <name name-style="western"><surname>Surowy</surname> <given-names>HM</given-names></name>, <name name-style="western"><surname>Rinckleb</surname> <given-names>AE</given-names></name>, <name name-style="western"><surname>Hoegel</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Predisposition for TMPRSS2-ERG fusion in prostate cancer by variants in DNA repair genes</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>. <year>2009</year>;<volume>18</volume>(<issue>11</issue>):<fpage>3030</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/1055-9965.EPI-09-0772" xlink:type="simple">10.1158/1055-9965.EPI-09-0772</ext-link></comment> <object-id pub-id-type="pmid">19861517</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref065"><label>65</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Makarova</surname> <given-names>AV</given-names></name>, <name name-style="western"><surname>Stodola</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>Burgers</surname> <given-names>PM</given-names></name>. <article-title>A four-subunit DNA polymerase zeta complex containing Pol delta accessory subunits is essential for PCNA-mediated mutagenesis</article-title>. <source>Nucleic Acids Res</source>. <year>2012</year>;<volume>40</volume>(<issue>22</issue>):<fpage>11618</fpage>–<lpage>26</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gks948" xlink:type="simple">10.1093/nar/gks948</ext-link></comment> <object-id pub-id-type="pmid">23066099</object-id>; PubMed Central PMCID: PMCPMC3526297.</mixed-citation></ref>
<ref id="pgen.1006842.ref066"><label>66</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gibbs</surname> <given-names>PE</given-names></name>, <name name-style="western"><surname>McDonald</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Woodgate</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Lawrence</surname> <given-names>CW</given-names></name>. <article-title>The relative roles in vivo of Saccharomyces cerevisiae Pol eta, Pol zeta, Rev1 protein and Pol32 in the bypass and mutation induction of an abasic site, T-T (6–4) photoadduct and T-T cis-syn cyclobutane dimer</article-title>. <source>Genetics</source>. <year>2005</year>;<volume>169</volume>(<issue>2</issue>):<fpage>575</fpage>–<lpage>82</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1534/genetics.104.034611" xlink:type="simple">10.1534/genetics.104.034611</ext-link></comment> <object-id pub-id-type="pmid">15520252</object-id>; PubMed Central PMCID: PMCPMC1449107.</mixed-citation></ref>
<ref id="pgen.1006842.ref067"><label>67</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Johnson</surname> <given-names>RE</given-names></name>, <name name-style="western"><surname>Yu</surname> <given-names>SL</given-names></name>, <name name-style="western"><surname>Prakash</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Prakash</surname> <given-names>L</given-names></name>. <article-title>Yeast DNA polymerase zeta (zeta) is essential for error-free replication past thymine glycol</article-title>. <source>Genes Dev</source>. <year>2003</year>;<volume>17</volume>(<issue>1</issue>):<fpage>77</fpage>–<lpage>87</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/gad.1048303" xlink:type="simple">10.1101/gad.1048303</ext-link></comment> <object-id pub-id-type="pmid">12514101</object-id>; PubMed Central PMCID: PMCPMC195962.</mixed-citation></ref>
<ref id="pgen.1006842.ref068"><label>68</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Masuda</surname> <given-names>Y</given-names></name> <name name-style="western"><surname>HFa</surname> <given-names>CM</given-names></name>. <source>Translesion DNA synthesis and damage tolerance pathways</source>. <name name-style="western"><surname>Sugasawa</surname> <given-names>FHaK</given-names></name>, editor. <publisher-loc>Japan</publisher-loc>: <publisher-name>Springer</publisher-name>; <year>2016</year>.</mixed-citation></ref>
<ref id="pgen.1006842.ref069"><label>69</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>J</surname> <given-names>OW</given-names></name>, <name name-style="western"><surname>Kajiwara</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kawamura</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kimura</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Miyagishima</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Koseki</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>An essential role for REV3 in mammalian cell survival: absence of REV3 induces p53-independent embryonic death</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2002</year>;<volume>293</volume>(<issue>3</issue>):<fpage>1132</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0006-291X(02)00341-8" xlink:type="simple">10.1016/S0006-291X(02)00341-8</ext-link></comment> <object-id pub-id-type="pmid">12051777</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref070"><label>70</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Van Sloun</surname> <given-names>PP</given-names></name>, <name name-style="western"><surname>Varlet</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Sonneveld</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Boei</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Romeijn</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>Eeken</surname> <given-names>JC</given-names></name>, <etal>et al</etal>. <article-title>Involvement of mouse Rev3 in tolerance of endogenous and exogenous DNA damage</article-title>. <source>Mol Cell Biol</source>. <year>2002</year>;<volume>22</volume>(<issue>7</issue>):<fpage>2159</fpage>–<lpage>69</lpage>. <object-id pub-id-type="pmid">11884603</object-id>; PubMed Central PMCID: PMCPMC133679. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/MCB.22.7.2159-2169.2002" xlink:type="simple">10.1128/MCB.22.7.2159-2169.2002</ext-link></comment></mixed-citation></ref>
<ref id="pgen.1006842.ref071"><label>71</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wittschieben</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Shivji</surname> <given-names>MK</given-names></name>, <name name-style="western"><surname>Lalani</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Jacobs</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Marini</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Gearhart</surname> <given-names>PJ</given-names></name>, <etal>et al</etal>. <article-title>Disruption of the developmentally regulated Rev3l gene causes embryonic lethality</article-title>. <source>Curr Biol</source>. <year>2000</year>;<volume>10</volume>(<issue>19</issue>):<fpage>1217</fpage>–<lpage>20</lpage>. <object-id pub-id-type="pmid">11050392</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref072"><label>72</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bemark</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Khamlichi</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>Davies</surname> <given-names>SL</given-names></name>, <name name-style="western"><surname>Neuberger</surname> <given-names>MS</given-names></name>. <article-title>Disruption of mouse polymerase zeta (Rev3) leads to embryonic lethality and impairs blastocyst development in vitro</article-title>. <source>Curr Biol</source>. <year>2000</year>;<volume>10</volume>(<issue>19</issue>):<fpage>1213</fpage>–<lpage>6</lpage>. <object-id pub-id-type="pmid">11050391</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref073"><label>73</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lange</surname> <given-names>SS</given-names></name>, <name name-style="western"><surname>Bedford</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Reh</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Wittschieben</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Carbajal</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kusewitt</surname> <given-names>DF</given-names></name>, <etal>et al</etal>. <article-title>Dual role for mammalian DNA polymerase zeta in maintaining genome stability and proliferative responses</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2013</year>;<volume>110</volume>(<issue>8</issue>):<fpage>E687</fpage>–<lpage>96</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1217425110" xlink:type="simple">10.1073/pnas.1217425110</ext-link></comment> <object-id pub-id-type="pmid">23386725</object-id>; PubMed Central PMCID: PMCPMC3581960.</mixed-citation></ref>
<ref id="pgen.1006842.ref074"><label>74</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lange</surname> <given-names>SS</given-names></name>, <name name-style="western"><surname>Wittschieben</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Wood</surname> <given-names>RD</given-names></name>. <article-title>DNA polymerase zeta is required for proliferation of normal mammalian cells</article-title>. <source>Nucleic Acids Res</source>. <year>2012</year>;<volume>40</volume>(<issue>10</issue>):<fpage>4473</fpage>–<lpage>82</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gks054" xlink:type="simple">10.1093/nar/gks054</ext-link></comment> <object-id pub-id-type="pmid">22319213</object-id>; PubMed Central PMCID: PMCPMC3378892.</mixed-citation></ref>
<ref id="pgen.1006842.ref075"><label>75</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Watanabe</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Mii</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Asai</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Asai</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Niimi</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Ushida</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>The REV7 subunit of DNA polymerase zeta is essential for primordial germ cell maintenance in the mouse</article-title>. <source>J Biol Chem</source>. <year>2013</year>;<volume>288</volume>(<issue>15</issue>):<fpage>10459</fpage>–<lpage>71</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M112.421966" xlink:type="simple">10.1074/jbc.M112.421966</ext-link></comment> <object-id pub-id-type="pmid">23463509</object-id>; PubMed Central PMCID: PMCPMC3624428.</mixed-citation></ref>
<ref id="pgen.1006842.ref076"><label>76</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jansen</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>Langerak</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Tsaalbi-Shtylik</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>van den Berk</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Jacobs</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>de Wind</surname> <given-names>N</given-names></name>. <article-title>Strand-biased defect in C/G transversions in hypermutating immunoglobulin genes in Rev1-deficient mice</article-title>. <source>J Exp Med</source>. <year>2006</year>;<volume>203</volume>(<issue>2</issue>):<fpage>319</fpage>–<lpage>23</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1084/jem.20052227" xlink:type="simple">10.1084/jem.20052227</ext-link></comment> <object-id pub-id-type="pmid">16476771</object-id>; PubMed Central PMCID: PMCPMC2118202.</mixed-citation></ref>
<ref id="pgen.1006842.ref077"><label>77</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Niimi</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Murakumo</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Watanabe</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Kato</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Mii</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Enomoto</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Suppression of REV7 enhances cisplatin sensitivity in ovarian clear cell carcinoma cells</article-title>. <source>Cancer Sci</source>. <year>2014</year>;<volume>105</volume>(<issue>5</issue>):<fpage>545</fpage>–<lpage>52</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/cas.12390" xlink:type="simple">10.1111/cas.12390</ext-link></comment> <object-id pub-id-type="pmid">24597627</object-id>; PubMed Central PMCID: PMCPMC4317831.</mixed-citation></ref>
<ref id="pgen.1006842.ref078"><label>78</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xu</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Chapman</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Brandsma</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Yuan</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Mistrik</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Bouwman</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>REV7 counteracts DNA double-strand break resection and affects PARP inhibition</article-title>. <source>Nature</source>. <year>2015</year>;<volume>521</volume>(<issue>7553</issue>):<fpage>541</fpage>–<lpage>4</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature14328" xlink:type="simple">10.1038/nature14328</ext-link></comment> <object-id pub-id-type="pmid">25799992</object-id>; PubMed Central PMCID: PMCPMC4671316.</mixed-citation></ref>
<ref id="pgen.1006842.ref079"><label>79</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Okina</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Yanagisawa</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Yokoyama</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sakurai</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Numata</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Umezawa</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>High expression of REV7 is an independent prognostic indicator in patients with diffuse large B-cell lymphoma treated with rituximab</article-title>. <source>Int J Hematol</source>. <year>2015</year>;<volume>102</volume>(<issue>6</issue>):<fpage>662</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s12185-015-1880-3" xlink:type="simple">10.1007/s12185-015-1880-3</ext-link></comment> <object-id pub-id-type="pmid">26449786</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref080"><label>80</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rimkus</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Friederichs</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Rosenberg</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Holzmann</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Siewert</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Janssen</surname> <given-names>KP</given-names></name>. <article-title>Expression of the mitotic checkpoint gene MAD2L2 has prognostic significance in colon cancer</article-title>. <source>Int J Cancer</source>. <year>2007</year>;<volume>120</volume>(<issue>1</issue>):<fpage>207</fpage>–<lpage>11</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ijc.22155" xlink:type="simple">10.1002/ijc.22155</ext-link></comment> <object-id pub-id-type="pmid">17044027</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref081"><label>81</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname> <given-names>W</given-names></name>. <article-title>Damage repair DNA polymerases Y</article-title>. <source>Curr Opin Struct Biol</source>. <year>2003</year>;<volume>13</volume>(<issue>1</issue>):<fpage>23</fpage>–<lpage>30</lpage>. <object-id pub-id-type="pmid">12581656</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref082"><label>82</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname> <given-names>W</given-names></name>. <article-title>Potraits of a Y-family DNA polymerase</article-title>. <source>FEBS Lett</source>. <year>2005</year>;<volume>579</volume>:<fpage>868</fpage>–<lpage>72</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.febslet.2004.11.047" xlink:type="simple">10.1016/j.febslet.2004.11.047</ext-link></comment> <object-id pub-id-type="pmid">15680965</object-id></mixed-citation></ref>
<ref id="pgen.1006842.ref083"><label>83</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ling</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Boudsocq</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Plosky</surname> <given-names>BS</given-names></name>, <name name-style="western"><surname>Woodgate</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>W</given-names></name>. <article-title>Replication of a cis-syn thymine dimer at atomic resolution</article-title>. <source>Nature</source>. <year>2003</year>;<volume>424</volume>(<issue>6952</issue>):<fpage>1083</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature01919" xlink:type="simple">10.1038/nature01919</ext-link></comment> <object-id pub-id-type="pmid">12904819</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref084"><label>84</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lone</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Townson</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Uljon</surname> <given-names>SN</given-names></name>, <name name-style="western"><surname>Johnson</surname> <given-names>RE</given-names></name>, <name name-style="western"><surname>Brahma</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Nair</surname> <given-names>DT</given-names></name>, <etal>et al</etal>. <article-title>Human DNA polymerase kappa encircles DNA: implications for mismatch extension and lesion bypass</article-title>. <source>Mol Cell</source>. <year>2007</year>;<volume>25</volume>(<issue>4</issue>):<fpage>601</fpage>–<lpage>14</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molcel.2007.01.018" xlink:type="simple">10.1016/j.molcel.2007.01.018</ext-link></comment> <object-id pub-id-type="pmid">17317631</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref085"><label>85</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Trincao</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Johnson</surname> <given-names>RE</given-names></name>, <name name-style="western"><surname>Escalante</surname> <given-names>CR</given-names></name>, <name name-style="western"><surname>Prakash</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Prakash</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Aggarwal</surname> <given-names>AK</given-names></name>. <article-title>Structure of the catalytic core of S. cerevisiae DNA polymerase eta: implications for translesion DNA synthesis</article-title>. <source>Mol Cell</source>. <year>2001</year>;<volume>8</volume>(<issue>2</issue>):<fpage>417</fpage>–<lpage>26</lpage>. <object-id pub-id-type="pmid">11545743</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref086"><label>86</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jansen</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>Tsaalbi-Shtylik</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Hendriks</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Verspuy</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Gali</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Haracska</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Mammalian polymerase zeta is essential for post-replication repair of UV-induced DNA lesions</article-title>. <source>DNA Repair (Amst)</source>. <year>2009</year>;<volume>8</volume>(<issue>12</issue>):<fpage>1444</fpage>–<lpage>51</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.dnarep.2009.09.006" xlink:type="simple">10.1016/j.dnarep.2009.09.006</ext-link></comment> <object-id pub-id-type="pmid">19783229</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref087"><label>87</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jansen</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>Tsaalbi-Shtylik</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Hendriks</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Gali</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Hendel</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Johansson</surname> <given-names>F</given-names></name>, <etal>et al</etal>. <article-title>Separate domains of Rev1 mediate two modes of DNA damage bypass in mammalian cells</article-title>. <source>Mol Cell Biol</source>. <year>2009</year>;<volume>29</volume>(<issue>11</issue>):<fpage>3113</fpage>–<lpage>23</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/MCB.00071-09" xlink:type="simple">10.1128/MCB.00071-09</ext-link></comment> <object-id pub-id-type="pmid">19332561</object-id>; PubMed Central PMCID: PMCPMC2682010.</mixed-citation></ref>
<ref id="pgen.1006842.ref088"><label>88</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Goodman</surname> <given-names>MF</given-names></name>, <name name-style="western"><surname>Woodgate</surname> <given-names>R</given-names></name>. <article-title>Translesion DNA polymerases</article-title>. <source>Cold Spring Harb Perspect Biol</source>. <year>2013</year>;<volume>5</volume>(<issue>10</issue>):<fpage>a010363</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/cshperspect.a010363" xlink:type="simple">10.1101/cshperspect.a010363</ext-link></comment> <object-id pub-id-type="pmid">23838442</object-id>; PubMed Central PMCID: PMCPMC3783050.</mixed-citation></ref>
<ref id="pgen.1006842.ref089"><label>89</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Woodgate</surname> <given-names>R</given-names></name>. <article-title>What a difference a decade makes: insights into translesion DNA synthesis</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2007</year>;<volume>104</volume>(<issue>40</issue>):<fpage>15591</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.0704219104" xlink:type="simple">10.1073/pnas.0704219104</ext-link></comment> <object-id pub-id-type="pmid">17898175</object-id>; PubMed Central PMCID: PMCPMC2000391.</mixed-citation></ref>
<ref id="pgen.1006842.ref090"><label>90</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pustovalova</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Magalhaes</surname> <given-names>MT</given-names></name>, <name name-style="western"><surname>D'Souza</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Rizzo</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>Korza</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Walker</surname> <given-names>GC</given-names></name>, <etal>et al</etal>. <article-title>Interaction between the Rev1 C-Terminal Domain and the PolD3 Subunit of Polzeta Suggests a Mechanism of Polymerase Exchange upon Rev1/Polzeta-Dependent Translesion Synthesis</article-title>. <source>Biochemistry</source>. <year>2016</year>;<volume>55</volume>(<issue>13</issue>):<fpage>2043</fpage>–<lpage>53</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1021/acs.biochem.5b01282" xlink:type="simple">10.1021/acs.biochem.5b01282</ext-link></comment> <object-id pub-id-type="pmid">26982350</object-id>; PubMed Central PMCID: PMCPMC4898654.</mixed-citation></ref>
<ref id="pgen.1006842.ref091"><label>91</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pozhidaeva</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Pustovalova</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>D'Souza</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Bezsonova</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Walker</surname> <given-names>GC</given-names></name>, <name name-style="western"><surname>Korzhnev</surname> <given-names>DM</given-names></name>. <article-title>NMR structure and dynamics of the C-terminal domain from human Rev1 and its complex with Rev1 interacting region of DNA polymerase eta</article-title>. <source>Biochemistry</source>. <year>2012</year>;<volume>51</volume>(<issue>27</issue>):<fpage>5506</fpage>–<lpage>20</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1021/bi300566z" xlink:type="simple">10.1021/bi300566z</ext-link></comment> <object-id pub-id-type="pmid">22691049</object-id>; PubMed Central PMCID: PMCPMC3732116.</mixed-citation></ref>
<ref id="pgen.1006842.ref092"><label>92</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sale</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Batters</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Edmunds</surname> <given-names>CE</given-names></name>, <name name-style="western"><surname>Phillips</surname> <given-names>LG</given-names></name>, <name name-style="western"><surname>Simpson</surname> <given-names>LJ</given-names></name>, <name name-style="western"><surname>Szuts</surname> <given-names>D</given-names></name>. <article-title>Timing matters: error-prone gap filling and translesion synthesis in immunoglobulin gene hypermutation</article-title>. <source>Philos Trans R Soc Lond B Biol Sci</source>. <year>2009</year>;<volume>364</volume>(<issue>1517</issue>):<fpage>595</fpage>–<lpage>603</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1098/rstb.2008.0197" xlink:type="simple">10.1098/rstb.2008.0197</ext-link></comment> <object-id pub-id-type="pmid">19008194</object-id>; PubMed Central PMCID: PMCPMC2660919.</mixed-citation></ref>
<ref id="pgen.1006842.ref093"><label>93</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Waters</surname> <given-names>LS</given-names></name>, <name name-style="western"><surname>Walker</surname> <given-names>GC</given-names></name>. <article-title>The critical mutagenic translesion DNA polymerase Rev1 is highly expressed during G(2)/M phase rather than S phase</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2006</year>;<volume>103</volume>(<issue>24</issue>):<fpage>8971</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.0510167103" xlink:type="simple">10.1073/pnas.0510167103</ext-link></comment> <object-id pub-id-type="pmid">16751278</object-id>; PubMed Central PMCID: PMCPMC1482550.</mixed-citation></ref>
<ref id="pgen.1006842.ref094"><label>94</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Minko</surname> <given-names>IG</given-names></name>, <name name-style="western"><surname>Harbut</surname> <given-names>MB</given-names></name>, <name name-style="western"><surname>Kozekov</surname> <given-names>ID</given-names></name>, <name name-style="western"><surname>Kozekova</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Jakobs</surname> <given-names>PM</given-names></name>, <name name-style="western"><surname>Olson</surname> <given-names>SB</given-names></name>, <etal>et al</etal>. <article-title>Role for DNA polymerase kappa in the processing of N2-N2-guanine interstrand cross-links</article-title>. <source>J Biol Chem</source>. <year>2008</year>;<volume>283</volume>(<issue>25</issue>):<fpage>17075</fpage>–<lpage>82</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M801238200" xlink:type="simple">10.1074/jbc.M801238200</ext-link></comment> <object-id pub-id-type="pmid">18434313</object-id>; PubMed Central PMCID: PMCPMC2427349.</mixed-citation></ref>
<ref id="pgen.1006842.ref095"><label>95</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Klug</surname> <given-names>AR</given-names></name>, <name name-style="western"><surname>Harbut</surname> <given-names>MB</given-names></name>, <name name-style="western"><surname>Lloyd</surname> <given-names>RS</given-names></name>, <name name-style="western"><surname>Minko</surname> <given-names>IG</given-names></name>. <article-title>Replication bypass of N2-deoxyguanosine interstrand cross-links by human DNA polymerases eta and iota</article-title>. <source>Chem Res Toxicol</source>. <year>2012</year>;<volume>25</volume>(<issue>3</issue>):<fpage>755</fpage>–<lpage>62</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1021/tx300011w" xlink:type="simple">10.1021/tx300011w</ext-link></comment> <object-id pub-id-type="pmid">22332732</object-id>; PubMed Central PMCID: PMCPMC3723381.</mixed-citation></ref>
<ref id="pgen.1006842.ref096"><label>96</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ho</surname> <given-names>TV</given-names></name>, <name name-style="western"><surname>Guainazzi</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Derkunt</surname> <given-names>SB</given-names></name>, <name name-style="western"><surname>Enoiu</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Scharer</surname> <given-names>OD</given-names></name>. <article-title>Structure-dependent bypass of DNA interstrand crosslinks by translesion synthesis polymerases</article-title>. <source>Nucleic Acids Res</source>. <year>2011</year>;<volume>39</volume>(<issue>17</issue>):<fpage>7455</fpage>–<lpage>64</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gkr448" xlink:type="simple">10.1093/nar/gkr448</ext-link></comment> <object-id pub-id-type="pmid">21666254</object-id>; PubMed Central PMCID: PMCPMC3177197.</mixed-citation></ref>
<ref id="pgen.1006842.ref097"><label>97</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Raschle</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Knipscheer</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Enoiu</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Angelov</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Sun</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Griffith</surname> <given-names>JD</given-names></name>, <etal>et al</etal>. <article-title>Mechanism of replication-coupled DNA interstrand crosslink repair</article-title>. <source>Cell</source>. <year>2008</year>;<volume>134</volume>(<issue>6</issue>):<fpage>969</fpage>–<lpage>80</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2008.08.030" xlink:type="simple">10.1016/j.cell.2008.08.030</ext-link></comment> <object-id pub-id-type="pmid">18805090</object-id>; PubMed Central PMCID: PMCPMC2748255.</mixed-citation></ref>
<ref id="pgen.1006842.ref098"><label>98</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Clauson</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Scharer</surname> <given-names>OD</given-names></name>, <name name-style="western"><surname>Niedernhofer</surname> <given-names>L</given-names></name>. <article-title>Advances in understanding the complex mechanisms of DNA interstrand cross-link repair</article-title>. <source>Cold Spring Harb Perspect Biol</source>. <year>2013</year>;<volume>5</volume>(<issue>10</issue>):<fpage>a012732</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/cshperspect.a012732" xlink:type="simple">10.1101/cshperspect.a012732</ext-link></comment> <object-id pub-id-type="pmid">24086043</object-id>; PubMed Central PMCID: PMCPMC4123742.</mixed-citation></ref>
<ref id="pgen.1006842.ref099"><label>99</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Scharer</surname> <given-names>OD</given-names></name>. <article-title>Nucleotide excision repair in eukaryotes</article-title>. <source>Cold Spring Harb Perspect Biol</source>. <year>2013</year>;<volume>5</volume>(<issue>10</issue>):<fpage>a012609</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/cshperspect.a012609" xlink:type="simple">10.1101/cshperspect.a012609</ext-link></comment> <object-id pub-id-type="pmid">24086042</object-id>; PubMed Central PMCID: PMCPMC3783044.</mixed-citation></ref>
<ref id="pgen.1006842.ref100"><label>100</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Krokan</surname> <given-names>HE</given-names></name>, <name name-style="western"><surname>Bjoras</surname> <given-names>M</given-names></name>. <article-title>Base excision repair</article-title>. <source>Cold Spring Harb Perspect Biol</source>. <year>2013</year>;<volume>5</volume>(<issue>4</issue>):<fpage>a012583</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/cshperspect.a012583" xlink:type="simple">10.1101/cshperspect.a012583</ext-link></comment> <object-id pub-id-type="pmid">23545420</object-id>; PubMed Central PMCID: PMCPMC3683898.</mixed-citation></ref>
<ref id="pgen.1006842.ref101"><label>101</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sakofsky</surname> <given-names>CJ</given-names></name>, <name name-style="western"><surname>Ayyar</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Deem</surname> <given-names>AK</given-names></name>, <name name-style="western"><surname>Chung</surname> <given-names>WH</given-names></name>, <name name-style="western"><surname>Ira</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Malkova</surname> <given-names>A</given-names></name>. <article-title>Translesion Polymerases Drive Microhomology-Mediated Break-Induced Replication Leading to Complex Chromosomal Rearrangements</article-title>. <source>Mol Cell</source>. <year>2015</year>;<volume>60</volume>(<issue>6</issue>):<fpage>860</fpage>–<lpage>72</lpage>. Epub 2015/12/17. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molcel.2015.10.041" xlink:type="simple">10.1016/j.molcel.2015.10.041</ext-link></comment> <object-id pub-id-type="pmid">26669261</object-id>; PubMed Central PMCID: PMC4688117.</mixed-citation></ref>
<ref id="pgen.1006842.ref102"><label>102</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kawamoto</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Araki</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Sonoda</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Yamashita</surname> <given-names>YM</given-names></name>, <name name-style="western"><surname>Harada</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kikuchi</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Dual roles for DNA polymerase eta in homologous DNA recombination and translesion DNA synthesis</article-title>. <source>Mol Cell</source>. <year>2005</year>;<volume>20</volume>(<issue>5</issue>):<fpage>793</fpage>–<lpage>9</lpage>. Epub 2005/12/13. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molcel.2005.10.016" xlink:type="simple">10.1016/j.molcel.2005.10.016</ext-link></comment> <object-id pub-id-type="pmid">16337602</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref103"><label>103</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sarkies</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Reams</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Simpson</surname> <given-names>LJ</given-names></name>, <name name-style="western"><surname>Sale</surname> <given-names>JE</given-names></name>. <article-title>Epigenetic instability due to defective replication of structured DNA</article-title>. <source>Mol Cell</source>. <year>2010</year>;<volume>40</volume>(<issue>5</issue>):<fpage>703</fpage>–<lpage>13</lpage>. Epub 2010/12/15. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molcel.2010.11.009" xlink:type="simple">10.1016/j.molcel.2010.11.009</ext-link></comment> <object-id pub-id-type="pmid">21145480</object-id>; PubMed Central PMCID: PMC3145961.</mixed-citation></ref>
<ref id="pgen.1006842.ref104"><label>104</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Boersma</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Moatti</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Segura-Bayona</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Peuscher</surname> <given-names>MH</given-names></name>, <name name-style="western"><surname>van der Torre</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Wevers</surname> <given-names>BA</given-names></name>, <etal>et al</etal>. <article-title>MAD2L2 controls DNA repair at telomeres and DNA breaks by inhibiting 5' end resection</article-title>. <source>Nature</source>. <year>2015</year>;<volume>521</volume>(<issue>7553</issue>):<fpage>537</fpage>–<lpage>40</lpage>. Epub 2015/03/25. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature14216" xlink:type="simple">10.1038/nature14216</ext-link></comment> <object-id pub-id-type="pmid">25799990</object-id>; PubMed Central PMCID: PMC4481296.</mixed-citation></ref>
<ref id="pgen.1006842.ref105"><label>105</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chun</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>Kok</surname> <given-names>KH</given-names></name>, <name name-style="western"><surname>Jin</surname> <given-names>DY</given-names></name>. <article-title>REV7 is required for anaphase-promoting complex-dependent ubiquitination and degradation of translesion DNA polymerase REV1</article-title>. <source>Cell Cycle</source>. <year>2013</year>;<volume>12</volume>(<issue>2</issue>):<fpage>365</fpage>–<lpage>78</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4161/cc.23214" xlink:type="simple">10.4161/cc.23214</ext-link></comment> <object-id pub-id-type="pmid">23287467</object-id>; PubMed Central PMCID: PMCPMC3575465.</mixed-citation></ref>
<ref id="pgen.1006842.ref106"><label>106</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Doles</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Oliver</surname> <given-names>TG</given-names></name>, <name name-style="western"><surname>Cameron</surname> <given-names>ER</given-names></name>, <name name-style="western"><surname>Hsu</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Jacks</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Walker</surname> <given-names>GC</given-names></name>, <etal>et al</etal>. <article-title>Suppression of Rev3, the catalytic subunit of Pol{zeta}, sensitizes drug-resistant lung tumors to chemotherapy</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2010</year>;<volume>107</volume>(<issue>48</issue>):<fpage>20786</fpage>–<lpage>91</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1011409107" xlink:type="simple">10.1073/pnas.1011409107</ext-link></comment> <object-id pub-id-type="pmid">21068376</object-id>; PubMed Central PMCID: PMCPMC2996428.</mixed-citation></ref>
<ref id="pgen.1006842.ref107"><label>107</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xie</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Doles</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Hemann</surname> <given-names>MT</given-names></name>, <name name-style="western"><surname>Walker</surname> <given-names>GC</given-names></name>. <article-title>Error-prone translesion synthesis mediates acquired chemoresistance</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2010</year>;<volume>107</volume>(<issue>48</issue>):<fpage>20792</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1011412107" xlink:type="simple">10.1073/pnas.1011412107</ext-link></comment> <object-id pub-id-type="pmid">21068378</object-id>; PubMed Central PMCID: PMCPMC2996453.</mixed-citation></ref>
<ref id="pgen.1006842.ref108"><label>108</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xu</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Xie</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>XQ</given-names></name>, <name name-style="western"><surname>Pridgen</surname> <given-names>EM</given-names></name>, <name name-style="western"><surname>Park</surname> <given-names>GY</given-names></name>, <name name-style="western"><surname>Cui</surname> <given-names>DS</given-names></name>, <etal>et al</etal>. <article-title>Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2013</year>;<volume>110</volume>(<issue>46</issue>):<fpage>18638</fpage>–<lpage>43</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1303958110" xlink:type="simple">10.1073/pnas.1303958110</ext-link></comment> <object-id pub-id-type="pmid">24167294</object-id>; PubMed Central PMCID: PMCPMC3832000.</mixed-citation></ref>
<ref id="pgen.1006842.ref109"><label>109</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Shi</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Ren</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>REV3L, a promising target in regulating the chemosensitivity of cervical cancer cells</article-title>. <source>PLoS ONE</source>. <year>2015</year>;<volume>10</volume>(<issue>3</issue>):<fpage>e0120334</fpage>. Epub 2015/03/18. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0120334" xlink:type="simple">10.1371/journal.pone.0120334</ext-link></comment> <object-id pub-id-type="pmid">25781640</object-id>; PubMed Central PMCID: PMC4364373.</mixed-citation></ref>
<ref id="pgen.1006842.ref110"><label>110</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Sheng</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Yu</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Cao</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Zhou</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>REV3L modulates cisplatin sensitivity of non-small cell lung cancer H1299 cells</article-title>. <source>Oncology reports</source>. <year>2015</year>;<volume>34</volume>(<issue>3</issue>):<fpage>1460</fpage>–<lpage>8</lpage>. Epub 2015/07/15. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3892/or.2015.4121" xlink:type="simple">10.3892/or.2015.4121</ext-link></comment> <object-id pub-id-type="pmid">26165320</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref111"><label>111</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bartz</surname> <given-names>SR</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Burchard</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Imakura</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Martin</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Palmieri</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Small interfering RNA screens reveal enhanced cisplatin cytotoxicity in tumor cells having both BRCA network and TP53 disruptions</article-title>. <source>Mol Cell Biol</source>. <year>2006</year>;<volume>26</volume>(<issue>24</issue>):<fpage>9377</fpage>–<lpage>86</lpage>. Epub 2006/09/27. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/MCB.01229-06" xlink:type="simple">10.1128/MCB.01229-06</ext-link></comment> <object-id pub-id-type="pmid">17000754</object-id>; PubMed Central PMCID: PMC1698535.</mixed-citation></ref>
<ref id="pgen.1006842.ref112"><label>112</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lord</surname> <given-names>CJ</given-names></name>, <name name-style="western"><surname>Tutt</surname> <given-names>AN</given-names></name>, <name name-style="western"><surname>Ashworth</surname> <given-names>A</given-names></name>. <article-title>Synthetic lethality and cancer therapy: lessons learned from the development of PARP inhibitors</article-title>. <source>Annual review of medicine</source>. <year>2015</year>;<volume>66</volume>:<fpage>455</fpage>–<lpage>70</lpage>. Epub 2014/10/24. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1146/annurev-med-050913-022545" xlink:type="simple">10.1146/annurev-med-050913-022545</ext-link></comment> <object-id pub-id-type="pmid">25341009</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref113"><label>113</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kotov</surname> <given-names>IN</given-names></name>, <name name-style="western"><surname>Siebring-van Olst</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Knobel</surname> <given-names>PA</given-names></name>, <name name-style="western"><surname>van der Meulen-Muileman</surname> <given-names>IH</given-names></name>, <name name-style="western"><surname>Felley-Bosco</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>van Beusechem</surname> <given-names>VW</given-names></name>, <etal>et al</etal>. <article-title>Whole genome RNAi screens reveal a critical role of REV3 in coping with replication stress</article-title>. <source>Molecular oncology</source>. <year>2014</year>;<volume>8</volume>(<issue>8</issue>):<fpage>1747</fpage>–<lpage>59</lpage>. Epub 2014/08/13. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molonc.2014.07.008" xlink:type="simple">10.1016/j.molonc.2014.07.008</ext-link></comment> <object-id pub-id-type="pmid">25113059</object-id>.</mixed-citation></ref>
<ref id="pgen.1006842.ref114"><label>114</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mohni</surname> <given-names>KN</given-names></name>, <name name-style="western"><surname>Thompson</surname> <given-names>PS</given-names></name>, <name name-style="western"><surname>Luzwick</surname> <given-names>JW</given-names></name>, <name name-style="western"><surname>Glick</surname> <given-names>GG</given-names></name>, <name name-style="western"><surname>Pendleton</surname> <given-names>CS</given-names></name>, <name name-style="western"><surname>Lehmann</surname> <given-names>BD</given-names></name>, <etal>et al</etal>. <article-title>A Synthetic Lethal Screen Identifies DNA Repair Pathways that Sensitize Cancer Cells to Combined ATR Inhibition and Cisplatin Treatments</article-title>. <source>PLoS ONE</source>. <year>2015</year>;<volume>10</volume>(<issue>5</issue>):<fpage>e0125482</fpage>. Epub 2015/05/13. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0125482" xlink:type="simple">10.1371/journal.pone.0125482</ext-link></comment> <object-id pub-id-type="pmid">25965342</object-id>; PubMed Central PMCID: PMC4428765.</mixed-citation></ref>
<ref id="pgen.1006842.ref115"><label>115</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sonoda</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Okada</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Zhao</surname> <given-names>GY</given-names></name>, <name name-style="western"><surname>Tateishi</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Araki</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Yamaizumi</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Multiple roles of Rev3, the catalytic subunit of polzeta in maintaining genome stability in vertebrates</article-title>. <source>EMBO J</source>. <year>2003</year>;<volume>22</volume>(<issue>12</issue>):<fpage>3188</fpage>–<lpage>97</lpage>. Epub 2003/06/14. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/emboj/cdg308" xlink:type="simple">10.1093/emboj/cdg308</ext-link></comment> <object-id pub-id-type="pmid">12805232</object-id>; PubMed Central PMCID: PMC162160.</mixed-citation></ref>
<ref id="pgen.1006842.ref116"><label>116</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yamanaka</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Dorjsuren</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Eoff</surname> <given-names>RL</given-names></name>, <name name-style="western"><surname>Egli</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Maloney</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Jadhav</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>A comprehensive strategy to discover inhibitors of the translesion synthesis DNA polymerase kappa</article-title>. <source>PLoS ONE</source>. <year>2012</year>;<volume>7</volume>(<issue>10</issue>):<fpage>e45032</fpage>. Epub 2012/10/12. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0045032" xlink:type="simple">10.1371/journal.pone.0045032</ext-link></comment> <object-id pub-id-type="pmid">23056190</object-id>; PubMed Central PMCID: PMC3466269.</mixed-citation></ref>
<ref id="pgen.1006842.ref117"><label>117</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mizushina</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Motoshima</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Yamaguchi</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Takeuchi</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Hirano</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Sugawara</surname> <given-names>F</given-names></name>, <etal>et al</etal>. <article-title>3-O-methylfunicone, a selective inhibitor of mammalian Y-family DNA polymerases from an Australian sea salt fungal strain</article-title>. <source>Marine drugs</source>. <year>2009</year>;<volume>7</volume>(<issue>4</issue>):<fpage>624</fpage>–<lpage>39</lpage>. Epub 2010/01/26. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/md7040624" xlink:type="simple">10.3390/md7040624</ext-link></comment> <object-id pub-id-type="pmid">20098603</object-id>; PubMed Central PMCID: PMC2810227.</mixed-citation></ref>
<ref id="pgen.1006842.ref118"><label>118</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Actis</surname> <given-names>ML</given-names></name>, <name name-style="western"><surname>Ambaye</surname> <given-names>ND</given-names></name>, <name name-style="western"><surname>Evison</surname> <given-names>BJ</given-names></name>, <name name-style="western"><surname>Shao</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Vanarotti</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Inoue</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Identification of the first small-molecule inhibitor of the REV7 DNA repair protein interaction</article-title>. <source>Bioorganic &amp; medicinal chemistry</source>. <year>2016</year>;<volume>24</volume>(<issue>18</issue>):<fpage>4339</fpage>–<lpage>46</lpage>. Epub 2016/07/28. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.bmc.2016.07.026" xlink:type="simple">10.1016/j.bmc.2016.07.026</ext-link></comment> <object-id pub-id-type="pmid">27448776</object-id>.</mixed-citation></ref>
</ref-list>
</back>
</article>